地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：13212737804
传真：15172469628
邮箱：sales@amyjet.com
Zedira是一家临床阶段的生物技术公司，专门从事转谷氨酰胺酶的研究，开发一系列小分子药物候选物。Zedira公司正致力于药物发现的前沿领域，该领域涉及阻止调节失调的转谷氨酰胺酶的小分子。此外，Zedira是一个全球品牌，专门用于转谷氨酰胺酶领域的研发和诊断试剂，其独特和高质量的产品有助于推动转谷氨酰胺酶的研究和应用。
Zedira is a clinical stage biotech company specialised in transglutaminase. Zedira conducts its own development of small molecular drug candidates. In doing so, the company is working at the cutting edge of drug discovery involving small molecules that block dysregulated transglutaminases. In addition, Zedira is a global brand for specialty reagents for research & development as well as diagnostics in the transglutaminase field. Numerous unique and high quality products help pushing forward transglutaminase-related science – both in academia and industry.
Zedira公司主要产品：
Transglutaminases
Microbial Transglutaminase
Assays and Substrates
Inhibitors
Antibodies and Microarrays
Proteases
Protein Labeling
Blood Coagulation
Cereal Proteins
Celiac Disease Products
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
Zedira产品详情请咨询我司客服人员：
| 产品编号 | 产品名称 | 产品规格 |
| A003 | Polyclonal antibody to human tissue transglutaminase (TG2) | 100 ug |
| A004 | Monoclonal antibody to tissue transglutaminase (TG2) | 100 ug |
| A008 | Polyclonal antibody to human transglutaminase 5 (TG5) | 500 ug |
| A011 | Monoclonal antibody to gliadin (clone XGY1) | 1 mg |
| A013 | Monoclonal antibody to gliadin (clone XGY7) | 1 mg |
| A014 | Polyclonal antibody to human tissue transglutaminase (TG2) | 500 ug |
| A015 | Polyclonal antibody to human epidermal transglutaminase (TG3) | 500 ug |
| A016 | Polyclonal antibody to human blood coagulation factor XIII (A-subunit) | 500 ug |
| A017 | Polyclonal antibody to human neuronal transglutaminase (TG6) | 500 ug |
| A018 | Polyclonal antibody to human keratinocyte transglutaminase (TGI) | 500 ug |
| A020 | Polyclonal antibody to microbial protransglutaminase (pro-MTG, pro-BTG) | 500 ug |
| A021 | Polyclonal antibody to human plasminogen (rhPLG) | 500 ug |
| A022 | Polyclonal antibody to human prostate transglutaminase (TG4) | 500 ug |
| A023 | Monoclonal antibody to N'-ly-L-glutamylpL-lysine-isopeptide bond | 100 ug |
| A024 | Monoclonal Antibody to microbial (bacterial) Transglutaminase | 100 ug |
| A028 | FITC-labeled polyclonal antibody to human TG2 | 200 ug |
| A029 | FITC-labeled polyclonal antibody to human TGI | 200 ug |
| A030 | FITC-labeled polyclonal antibody to human TG3 | 200 ug |
| A031 | FITC-labeled polyclonal antibody to human TG6 | 200 ug |
| A032 | FITC-labeled polyclonal antibody to human factor XIII (A-subunit) | 200 ug |
| A033 | Monoclonal antibody to human TG2 (Catalytic Domain, clone XTG17) | 200 ug |
| A034 | Monoclonal antibody to human TG2 (Beta Sheet Domain, clone XTG 1 1) | 200 ug |
| A035 | Monoclonal antibodies to gliadin (Set No 1) | 1 Set |
| A036 | Monoclonal antibody to human TG2 (Beta Barrel 1 Domain, clone XTG21) | 200 ug |
| A037 | Monoclonal antibody to human TG2 (Beta Barrel 2 Domain, clone XTG1 8) | 200 ug |
| A040 | Polyclonal antibody to human transglutaminase 7 (TG7) | 200 ug |
| A042 | Monoclonal antibody to human TGI (clone XTG3 1) | 200 ug |
| A044 | FITC-labeled polyclonal antibody to human TG5 | 200 ug |
| A046 | D-Dimer monoclonal mouse antibody, clone 3B6 | 100 ug |
| A047 | D-Dimer monoclonal mouse antibody, clone 1 D2 | 100 ug |
| A051 | Biotinylated polyclonal antibody to microbial transglutaminase (MTG) | 50 ug |
| A052 | Biotinylated polyclonal antibody to human factor XIII (A-subunit) | 50 ug |
| A053 | Biotinylated polyclonal antibody to human TG2 | 50 ug |
| A054 | Monoclonal antibody to gliadin (clone XGY6) | 1 mg |
| A057 | Monoclonal antibody to deamidated gliadin | 100 ug |
| A058 | Monoclonal antibody to gliadin (clone XGY5) | 1 mg |
| A059 | Monoclonal antibody to gliadin (clone XGY9) | 1 mg |
| A060 | Monoclonal antibody to gliadin (clone XGY10) | 1 mg |
| A061 | Monoclonal antibody to gliadin (clone XGY 1 6) | 1 mg |
| A062 | Monoclonal antibody to deamidated and non-deamidated gliadin | 100 ug |
| A063 | Monoclonal antibody to gliadin (clone XGY2) | 1 mg |
| A064 | Monoclonal antibody to gliadin (clone XGY4) | 1 mg |
| A065 | Monoclonal antibody to gliadin (clone XGY8) | 1 mg |
| A066 | Monoclonal antibody to gliadin (clone XGY 1 2) | 1 mg |
| A067 | Monoclonal antibody to gliadin (clone XGY 1 5) | 1 mg |
| A068 | Monoclonal antibody to gliadin (clone XGY 1 7) | 1 mg |
| A069 | Monoclonal antibody to gliadin (clone XGY23) | 1 mg |
| A070 | Monoclonal antibody to gliadin (clone XGY24) | 1 mg |
| A071 | Monoclonal antibody to hordein (clone XH4) | 1 mg |
| A072 | polyclonal antibody to mouse tissue Transglutaminse | 200 ug |
| A074 | Polyclonal antibody to human blood coagulation factor XIII (B-subunit) | 200 ug |
| A075 | FITC-labeled polyclonal antibody to mouse TG2 | 200 ug |
| A076 | DD-XLink-mab | 100 ug |
| A077 | FITC-labeled polyclonal antibody to human factor XIII (B-subunit) | 200 ug |
| A078 | Polyclonal antibody to human epidermal transglutaminase (TG3) Protein A | 250 ug |
| A079 | Biotin-DD-XLink-mab | 50 ug |
| A082 | Monoclonal antibody to human TG3 (clone XTG45) | 200 ug |
| A101 | FXIII-Assay Substance, Abz-NE(CAD-DNP)EQVSPLTLLK-OH | 10 mg |
| A102 | TG2-Assay Substance. Abz-APE(CAD-DNP)QEA-OH | 10 mg |
| A105 | NQEQVSPLTLLK, alpha2-Antiplasmin peptide (1-12) | 25 mg |
| A106 | (ATTO-48 8TM)cadaveri ne | 1 mg |
| A108 | Ac-(D)-Asp-MA-N le-Nle-Leu-Pro-Trp-Pro-OH | 5 mg |
| A109 | β-Amyloid peptide 1-42 (Aβ 1-42) | 1 mg |
| A112 | (ATTO-532)cadaverine | 1 mg |
| A113 | (ATTO-550)cadaverine | 1 mg |
| A114 | (AnO-647N)cadaverine | 1 mg |
| A115 | (ATTO-700)cadaverme | 1 mg |
| A125 | Factor XIII activation peptide | 10 mg |
| A132 | Ac-WALQRPHYSYPD | 10 mg |
| A139 | Monoclonal antibody to human TG6 (Catalytic Domain, clone XTG52) | 200 ug |
| A140 | Monoclonal antibody to human TG6 (Beta Barrel 1 Domain, clone XTG39) | 200 ug |
| A141 | Monoclonal antibody to human TG6 (Beta Barrel 1 Domain, clone XTG68) | 200 ug |
| A142 | Monoclonal antibody to human TG6 (Beta Barrel 2 Domain, clone XTG57) | 200 ug |
| A143 | Monoclonal antibody to microbial Transglutaminase (clone XM67) | 200 ug |
| A144 | Monoclonal antibody to microbial Transglutaminase (clone XM68) | 200 ug |
| A145 | Polyclonal Antibody to microbial Transglutaminase | 200 ug |
| A152 | 3-Azido-l -propanamine | 100 mg |
| A153 | 4-Azidobutan-l-amine | 100 mg |
| A154 | Monoclonal antibody to human factor XIII (Activation Peptide, clone XTG09) | 200 ug |
| A155 | Monoclonal antibody to human factor XIII (Catalytic Domain, clone XTG02) | 200 ug |
| B001 | Biotinyl-Thr-Val-GIn-GIn-Glu-Leu-OH | 5 mg 25 mg |
| B002 | N-(Biotinyl)cadaverine | 25 mg 100 mg |
| B003 | Boc-DON-Gln-lle-Val-OMez "Boc-DON” | 10 mg |
| B006 | Thr-Val-Gln-Gln-Glu-Leu-OH | 25 mg |
| B007 | Keratinocyte transglutaminase (TGI )-substrate-peptide K5 | 10 mg |
| B008 | Tissue transglutaminase (TG2)-substrate-peptide T26 | 10 mg |
| B009 | Epidermal transglutaminase (TG3)-substrate-peptide E51 | 10 mg |
| B010 | Blood coagulation FXIII-substrate-peptide Fl 1 KA | 10 mg |
| B013 | Neuronal transglutaminase (TG6)-substrate peptide Y25 | 10 mg |
| B014 | Transglutaminase 7 (TG7)-substrate peptide Z3S | 10 mg |
| B015 | Biotin-Ahx-MA-QPL-OMe | 10 mg |
| B017 | Microbial Transglutaminase (MTG)-substrate peptide M48 | 10 mg |
| B019 | Biotin-Ahx-QVPL-OMe | 10 mg |
| C001 | Z-GIn-Gly-OH | 1g |
| C002 | Z-GIn-Gly-CAD-DNS | 25 mg 100 mg |
| C074 | Z-Gln-Gly-CAD-(AnO-488) | 1 mg |
| C075 | Z-Gln-Gly-CAD-(ATTO-532) | 1 mg |
| C076 | Z-Gln-Gly-CAD-(AnO-550) | 1 mg |
| C077 | Z-Gln-Gly-CAD-(ATTO-647N) | 1 mg |
| C078 | Z-Gln-Gly-CAD-(AnO-700) | 1 mg |
| C079 | Z-GIn-Gly-PEG(3)-N3 | 25 mg |
| C080 | Z-Gln-Gly-PEG(11)-N3 | 25 mg |
| C090 | Z-GIn-Gly-CAD-TAMRA | 25 mg |
| C091 | Z-GIn-Gly-CAD-Biotin | 25 mg |
| C092 | Z-Gln-Gly-(PEG1,088), monodisperse | 25 mg |
| C093 | Z-Gln-Gly-(PEG5,000), polydisperse | 25 mg |
| C094 | Tosyl-ε-aminopentyl-CMK | 1 mg |
| C095 | Dansyl-ε-aminopentyl-CMK | 1 mg |
| C102 | MTG Blocker | 10 mg 25 mg |
| D001 | Dansyl-ε-aminohexanoyl-GIn-GIn-lle-Val-OH | 25 mg 100 mg |
| D002 | N-(2,4-Dinitrophenyl)cadaverine | 100 mg |
| D003 | 1,3-Dimethyl-2[(2-oxo-propyl)thio]imidazolium chloride | 100 mg |
| D004 | 1,3-Dimelhyl-4,5-diphenyl-2-[(2-oxopropyl)thio]imidazolium | 10 mg |
| D005 | Metalloprotease-Assay-Substance, DABCYL-Ser-Phe-EDANS | 2 mg |
| D006 | N-(Dansyl)cadaverine | 100 mg |
| D007 | Cadaverine | 100 mg |
| D008 | "DALP", DNP-aminohexanoic acid-Lys-aminopropanol | 5 mg |
| D009 | DALP-methyl carbamate | 5 mg |
| D0I 6 | LDN 27219 | 10 mg |
| E018 | ZediXclusive Tissue Transglutaminase EIA | 1 Kit |
| E021 | ZediXclusive Microbial Transglutaminase (MTG) ELISA | 1 Kit |
| E103 | ZediXclusive TG6-ab ELISA (IgA) | 1 Kit (96 wells) |
| E104 | ZediXclusive TG6-ab ELISA (IgG) | 1 Kit (96 wells) |
| F001 | FXIII-Assay Kit | 1 Kit |
| F002 | Tissue Transglutaminase Assay Kit | 1 Kit |
| F004 | Fibrinogen, purified from human plasma | 50 mg |
| F006 | FITC-labeled Fibrinogen | 5 mg |
| F007 | Fibrin Glue (porcine) | 1 Kit |
| F008 | Fibrin Glue (bovine) | 1 Kit |
| F011 | Cross-linked fibrin degradation products, xFDPs | 200 ug |
| F012 | Fibrin degradation products, FDPs | 200 ug |
| G001 | Alpha2-gliadin, 33mer (aa56-88), biotinylated | 5 mg |
| G002 | Deamidated alpha2-gliadin, 33mer (aa56-88), biotinylated | 5 mg |
| G003 | Ac-PLQPEQPFPK(ε-Biotin), Deamidated gliodin peptide | 10 mg |
| G004 | Ac-PEQLPQFEEK(ε-Biotin), Deamidated gliadin peptide | 10 mg |
| G005 | DGPx4 (Fusion protein of 4 deamidated gliadin peptides) | 500 ug |
| G006 | DGPx2 (Fusion protein of 2 deamidated gliadin peptides) | 500 ug |
| G007 | DGPxl (deamidated gliadin peptide) | 500 ug |
| G008 | Omega-5 gliadin | 500 ug |
| G009 | Alpha2-gliadin, 33mer (aa 56-88) | 5 mg |
| G011 | Deamidated alpha2-gliadin, 33mer, (Acetyl-aa56-88-amide, Q65E) | 5 mg |
| G013 | QPFPQPQLPYPQPQ-amide | 10 mg |
| G014 | QPFPQPELPYPQPQ-amide | 10 mg |
| G017 | Biotinylated DGPx1 | 100 ug |
| G018 | Barley albumin and globulin | 5 mg |
| G019 | Barley prolamin (Hordein) | 5 mg |
| G020 | Barley glutelin (Hordenin) | 5 mg |
| G021 | Rye albumin and globulin | 5 mg |
| G022 | Rye prolamin (Secalin) | 5 mg |
| G023 | Rye glutelin (Secalinin) | 5 mg |
| G024 | Corn albumin and globulin | 5 mg |
| G025 | Corn prolamin (Zein) | 5 mg |
| G026 | Corn glutelin (Zeanin) | 5 mg |
| G027 | Rice albumin and globulin | 5 mg |
| G028 | Rice prolamin (Oryzin) | 5 mg |
| G029 | Rice glutelin (Oryzenin) | 5 mg |
| G030 | Spell albumin and globulin | 5 mg |
| G031 | Spelt prolamin | 5 mg |
| G032 | Spelt glutelin | 5 mg |
| G033 | Oat albumin and globulin | 5 mg |
| G034 | Oat prolamin (Avenin) | 5 mg |
| G035 | Oat glutelin (Avenalin) | 5 mg |
| G036 | Wheat albumin and globulin (Leukosin and Edestin) | 5 mg |
| G037 | Wheat prolamin (Gliadin) | 5 mg |
| G038 | Wheat glutelin (Glutenin) | 5 mg |
| G039 | Durum wheat albumin and globulin | 5 mg |
| G040 | Durum wheat prolamin | 5 mg |
| G041 | Durum wheat glutelin | 5 mg |
| G042 | Soy protein, saline soluble fraction | 5 mg |
| G043 | Soy protein, ethanol soluble fraction | 5 mg |
| G044 | Soy protein, propanol/urea/DTE soluble fraction | 5 mg |
| G045 | Millet (Sorghum) albumin and globulin | 5 mg |
| G046 | Millet (Sorghum) prolamin (Kafirin) | 5 mg |
| G047 | Millet (Sorghum) glutelin | 5 mg |
| G048 | L-Glutamic acid γ-monohydroxamate | 100 mg |
| G051 | 26mer gliadin peptide | 250 ug |
| G052 | 33mer gliadin peptide | 250 ug |
| G054 | 33mer DGP | 250 ug |
| G055 | Carrier protein control | 250 ug |
| G056 | DGP and Gliadin peptides (Set No 1) | 1 Set |
| G057 | Alpha2-gliadin, 33mer (aa56-88), TAMRA labeled | 5 mg |
| G058 | Alpha2-gliadin, 33mer (aa56-88), TAMRA and Biotin labeled | 5 mg |
| G101 | Gly-Pro-Arg-Pro-amide | 25 mg |
| I001 | Involucrme, recombinant human | 500 ug |
| K004 | "KxD", Boc-Lys-en-DNS | 10 mg |
| L001 | Substrate Finder Kit | 1 Kit |
| L101 | Biotin TGase Protein Q-Labeling Kit | 1 Kit |
| L102 | PEG1,088 TGase Protein Q-Labeling Kit | 1 Kit |
| L103 | PEG5,000 TGase Protein Q-Labeling Kit | 1 kit |
| L104 | ATTO-488™ TGase Protein Q-Labeling Kit | 1 Kit |
| L105 | ATTO-532™ TGase Protein Q-Labeling Kit | 1 Kit |
| L106 | ATTO-550™ TGase Protein Q-Labeling Kit | 1 Kit |
| L107 | ATTO-647N™ TGase Protein Q-Labeling Kit | 1 Kit |
| L108 | ATTO-700™ TGase Protein Q-Labeling Kit | 1 Kit |
| L201 | Biotin TGase Protein K-Labeling Kit | 1 Kit |
| L202 | PEG1,088 TGase Protein K-Labeling Kit | 1 Kit |
| L203 | PEG5,000 TGase Protein K-Labeling Kit | 1 Kit |
| L204 | ATTO-488™ TGase Protein K-Labeling Kit | 1 Kit |
| L205 | ATTO-532™ TGase Protein K-Labeling Kit | 1 Kit |
| L206 | ATTO-550™ TGase Protein K-Labeling Kit | 1 Kit |
| L207 | ATTO-647N™ TGase Protein K-Labeling Kit | 1 Kit |
| L208 | ATTO-700™ TGase Protein K-Labeling Kit | 1 Kit |
| M001 | MTG-ANiTA-Kit | 1 Kit |
| M003 | Tissue Transglutaminase Pico-Assay Kit | 1 Kit |
| P003 | Prolylendopeptidase from Myxococcus xanthus, recombinant | 150U |
| P004 | PT-Gluten | 1 mg 10 mg |
| P009 | human Pro-Glu-Plasminogen, recombinant | 100 ug |
| P010 | (PEG1,088)amine, monodisperse | 10 mg |
| P011 | (PEG5,000)amine, polydisperse | 10 mg |
| P012 | human Plasmin, recombinant | 100 ug |
| P0U | Urokinase | 1 mg |
| P015 | Streptokinase (bacterial plasminogen activator) | 1 mg |
| P016 | Tissue Plasminogen Activator | 100 ug |
| P111 | PEPperCHIP Pan-Transglutaminase Microarray | 1 Chip |
| P112 | PEPperCHIP Custom Transglutaminase Microarray | 1 Chip |
| P113 | PEPperCHIP Transglutaminase Microarray Service | 1 Sample |
| P114 | PepSlide Analyzer | 3-Month/1-Year/Perpetual License |
| P115 | PEPperCHIP Incubation Tray 3/1 | 1 Tray |
| P116 | PEPperCHIP Staining Kit | 1 Kit |
| P117 | PEPperCHIP Transglutaminase 2 Microarray | 1 Chip |
| P118 | PEPperCHIP Incubation Tray 3/5 | 1 Tray |
| R001 | N-(Tetrametylrhodaminyl)cadaverine | 10 mg |
| R002 | TAMRA-DON | 5 mg 10 mg |
| T001 | Microbial (bacterial) transglutaminase | 25 U; 1 x 250 U;10x 25 U; lx 500 U; 20x 25 U |
| T002 | Human tissue transglutaminase (TG2) | 250 ug 1mg |
| T004 | N-(p-Tosyl)-Gly-Pro-Lys-pNA | 25 mg |
| T006 | Guinea pig liver transglutaminase | 10U |
| T009 | Human keratinocyte transglutaminase (TG1) | 150 ug |
| T011 | Human transglutaminase 7 | 250 ug |
| T013 | Human epidermal transglutaminase, Dispose activated | 200 ug |
| T016 | Microbial (bacterial) Pro-transglutaminase | 250 ug |
| T018 | Inactive human tissue transglutaminase | 250 ug 1 mg |
| T021 | Human neuronal transglutaminase (TG6) | 250 ug |
| T022 | Human tissue transglutaminase (TG2) | 250 ug 1 mg |
| T024 | Human epidermal transglutaminase (TG3) | 200 ug |
| T027 | Human blood coagulation Factor Xlll-A z recombinant | 200 ug |
| T034 | Human tissue transglutaminase (TG2) | 100 ug |
| T035 | Human keratinocyte transglutaminase (TGI) | 150 ug |
| T036 | Transglutaminase Assay Kit, fluorescent, Casein, Dansylcadaverine | 1 Kit |
| T038 | Rat tissue transglutaminase | 250 ug 1 mg |
| T039 | Guinea pig liver transglutaminase, recombinant | 10U |
| T040 | Mouse tissue transglutaminase | 250 ug 1 mg |
| T042 | Human prostate Transglutaminase (TG4) | 100 ug |
| T050 | Human blood coagulation Factor XIII B subunit | 200 ug |
| T051 | Open tTG™ | 250 ug |
| T055 | Tissue Transglutaminase Microassay Kit, colorimetric | 1 Kit |
| T056 | Human alpha thrombin, highly active | 200 U |
| T057 | Inhibited human epidermal transglutaminase | 250 ug |
| T061 | Mouse blood coagulation Factor Xlll-A2 | 200 ug |
| T062 | Dog blood coagulation Factor Xlll-A2 | 200 ug |
| T063 | Human blood coagulation Factor Xlll-A2 , Val34Leu-mutant | 200 ug |
| T064 | Inhibited human neuronal transglutaminase | 250 ug |
| T065 | Rat blood coagulation Factor Xlll-A2 | 200 ug |
| T066 | Pig blood coagulation Factor Xlll-A2 | 200 ug |
| T067 | Human tissue transglutaminase (TG2), endotoxin free | 250 ug 1 mg |
| T070 | Human Factor Xllla, Thrombin activated | 200 ug |
| T072 | Dog tissue transglutaminase | 250 ug 1 mg |
| T086 | Human Transglutaminase 5 | 100 ug |
| T087 | Tridegin | 200 ug |
| T092 | Human blood coagulation Factor Xlll-A2 | 100 ug |
| T101 | 1,3,4,5-Tetramethyl-2[(2-oxo-propyl)thio] imidazolium chloride | 10 mg |
| T102 | Mouse Open TG2 | 250 ug 1 mg |
| T106 | Biotinylated human tissue transglutaminase (TG2) | 100 ug 250 ug |
| T108 | Cynomolgus tissue transglutaminase | 250 ug |
| T109 | Cynomolgus open TG2 | 100 ug |
| T1 10 | Recombinant TG2 [E.coli] | 500 ug |
| T1 14 | Blood Coagulation Factor Xlll-Microassay Kit, colorimetric | 1 Kit |
| T117 | Biotinylated inactive hTG2 (Cys277Ser) | 250 ug 1 mg |
| T122 | Recombinant TG2 (insect cells) | 500 ug |
| T123 | Biotinylated human tissue transglutaminase (TG2) | 50 ug |
| T124 | Recombinant TG3 (insect cells) | 400 ug |
| T127 | Biotinylated human blood coagulation Factor XIII | 50 ug |
| T134 | Open tTG™ | 100 ug |
| T139 | Rabbit tissue transglutaminase | 250 ug 1mg |
| T140 | Biotinylated human epidermal transglutaminase | 100 ug |
| T141 | Biotinylated human neuronal transglutaminase | 100 ug |
| T142 | Biotinylated mouse blood coagulation Factor Xlll-A2 | 50 ug |
| T146 | Mouse neuronal transglutaminase | 250 ug |
| T148 | Biotinylated human Open tTG™ | 50 ug 1 mg |
| T149 | Oxidized inactive human tissue transglutaminase | 250 ug 1 mg |
| T150 | Biotinylated mouse open TG2 | 50 ug |
| T151 | Biotinylated oxidized inactive human tissue transglutaminase | 250 ug 1 mg |
| T152 | Rabbit blood coagulation Factor Xlll-A2 | 200 ug |
| T153 | Microbial (bacterial) transglutaminase, edotoxin free | 25 U;10x 25 U;20x 25 U |
| T156 | Biotinylated mouse tissue transglutaminase | 250 ug; 1 mg |
| T159 | Pig tissue transglutaminase | 250 ug; 1 mg |
| T160 | Biotinylated cynomolgus tissue transglutaminase | 50 ug |
| T161 | Cynomolgus blood coagulation Factor Xlll-A2 | 200 ug |
| T167 | Short human tissue transglutaminase, aa 1-475 | 250 ug |
| T168 | Human tissue transglutaminase, C23OA mutant | 250 ug;1 mg |
| T169 | Human tissue transglutaminase, R580A mutant | 250 ug;1 mg |
| T173 | Human tissue transglutaminase, R116C mutant | 1 mg |
| T178 | Microbial transglutaminase with C-terminal His6-tag | 25 U;10 x 25 U;20 x 25 U |
| T184 | Cat tissue transglutaminase | 200 ug |
| T187 | Factor XIII activation peptide, recombinant | 500 ug |
| T197 | Coagulation factor XIII, recombinant human Factor Xlll-A2 | 100E;250E |
| T222 | Human alpha Thrombin, recombinant | 100 NIH Units |
| Z004 | Z-Gln-GIn-Pro-Leu-OH | 25 mg |
| Z006 | Z-DON-Val-Pro-Leu-OMe,"Z-DON" | 10 mg |
| Z009 | ZediXclusive Microbial Transglutaminase Assay Kit | 1 Kit |
| Z010 | ZediXclusive Tissue Transglutaminase Assay Kit | 1 Kit |
| Z011 | Z-(D)-DON-Val-Pro-Leu-OMe | 10 mg |
| Z013 | Z-MA-QPL-OMe | 10 mg |
| Z015 | Keillor inhibitor AA9 | 10 mg |
| Z016 | Keillor inhibitor NC9 | 10 mg |
| Z017 | Keillor inhibitor VA4 | 10 mg |
LI-COR Biosciences分为三大业务板块：环境科学产品、生物技术产品、临床试验产品。
LI-COR technology enables scientists around the world to improve lives by advancing discovery. From the first low-cost light sensor filtered for the waveband absorbed by plants, to pioneering the development of near-infrared fluorescence detection systems for DNA sequencing, LI-COR strives to provide innovative solutions for researchers.
Today, LI-COR Biosciences is a leading innovator in systems for plant research, gas analysis, drug discovery, protein research, and small animal imaging.
LI-COR Biosciences的主要产品包括：
（1）Environmental Product Line
Eddy Covariance (CH4 " data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="LI-COR Biosciences">
LI-COR Biosciences
Pantomics公司成立于2004年，产品包含组织微阵列、组织切片、组织块，此外还提供组织样本定制生产服务。Pantomics公司具有完备的产品体系，研究者可根据研究物种、解剖学结构、病理状态，选择所需要的组织样本产品。
Pantomics, Inc. is a tissue array company founded by Dr. Langxing Pan, a pathologist, in 2004. The company makes and provides animal and human tissue arrays, for use in research, routine IHC/ISH control and education. Pantomics, Inc. also utilizes its own pathology resources to conduct tissue section-based RNA/protein analyses and/or target validation services for academia and industry.
Pantomics, Inc. has aimed at producing the highest standard tissue arrays for RNA and protein analyses. To achieve this, the company has established the following:
A strong scientific advisory board consisting of individuals with extensive experience in pathology diagnostics, teaching and research.
A dedicated tissue acquisition and processing center.
A work force of well trained technicians, scientists and pathologists.
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
Solulink公司致力于发展高性能的生物分子连接产品，他们不断的努力帮助你保持在生物科学研究的最前沿。可用于任何含有氨基的生物分子标记的ChromaLink™抗体标签试剂盒（ChromaLink™ Antibody Labeling Kit），和One-Shot（单标签）系列试剂盒的成功开发代表着他们始终如一地提供创新产品的承诺，以满足客户不断变化的需求。Solulink公司的产品包括：抗体标签、抗体-寡肽标签、生物素标签、磁珠及凝胶。
SoluLinK, Inc. provides linking reagents, conjugation kits, and conjugation services for life science research, diagnostics, and pharmaceutical markets. It offers biotin and digoxigenin labeling, magnetic beads and agarose, biotin and streptavidin, antibody labeling, antibody-oligo labeling, peptide linking and synthesis, and crosslinking products, as well as accessories. The company’s products are used in antibody, nanolink streptavidin magnetic beads, peptide conjugates, protein-peptide conjugates, solid phase peptide immobilization, streptavidin, protein conjugation kits, better biotin, and peplink linkable peptides applications. It offers its products through distributors and licensing partners in Australia, Austria, Belgium, Canada, China, the Czech Republic, Denmark, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, South Korea, the Netherlands, Portugal, the Russian Federation, Singapore, Spain, Sweden, Switzerland, Taiwan, the United Kingdom, and the United States. SoluLinK, Inc. was incorporated in 2000 and is based in San Diego, California.
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Solulink"> Solulink
艾美捷科技代理KRISHGEN BioSystems品牌ELISA试剂盒。
凭借在免疫学方面的深厚背景，KRISHGEN BioSystems提供经过充分验证的高质量检测试剂盒、试剂和耗材。
（1）产品分类：
抗药物抗体/免疫原性ELISA
双特异性抗体药物ELISA
融合蛋白ELISA
单克隆抗体药物中和抗体ELISA
肽药物抗体/肽抗体ELISA
跨膜蛋白质ELISA
基于TDM/MAb的生物类似物ELISA
宿主细胞蛋白ELISA
宿主细胞DNA污染检测
DsRNA检测ELISA
生物过程抗生素残留ELISA
生物过程残留物ELISA
专业凝血酶测定ELISA
生物标志物ELISA
（2）热门研究领域包括：
肿瘤学：肿瘤标志物和相关单克隆/双特异性抗体药物的特异性ELISA；
神经变性：神经变性标志物和相关mAb药物的特异性ELISA；
炎症：炎症和过敏标志物、细胞因子和相关单克隆抗体药物的特异性 ELISA；
糖尿病/代谢：代谢通路标志物和糖尿病生物类似药的特异性ELISA。
< " data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理KRISHGEN BioSystems品牌"> 艾美捷科技代理KRISHGEN BioSystems品牌
艾美捷科技代理Epicentre (LGC Biosearch, 原Lucigen)全系列产品。
Epicentre是一家核酸样品制备试剂以及酶的供应商，位于美国威斯康星州麦迪逊的Epicentre生物技术公司成立于1987年，是分子生物学产品的制造商和销售商，其产品广泛应用于RNA扩增及基因表达分析，基于转座子的遗传分析，核酸纯化，DNA序列分析，PCR及RT-PCR扩增，DNA及RNA修饰酶，基因组克隆，体外转录，以及蛋白质研究和纯化等领域。另外，公司拥有广泛的分子生物学产品生产线，可为客户提供蛋白质定制服务。Epicentre品牌现属于LGC集团旗下Lucigen公司。
Epicentre公司的主要产品包括：
| 品名 | 规格 | 货号 |
| 2'-dNTP (All 4 Mixed) | 10 μmole @ 2.5 mM ea. | D08104 |
| 2'-dNTP (All 4 mixed) | 10 μmole @ 25 mM ea. | D59104 |
| 2´-Fluorine-dCTP (2´-F-dCTP) Solution | 1 µmol | R2F110C |
| 2´-Fluorine-dUTP (2´-F-dUTP) Solution | 1 µmol | R2F110U |
| Ampligase® DNA Ligase with Buffer | 2,500 U @ 100 U/μl | A0102K |
| Ampligase® DNA Ligase without Buffer | 10,000 U @ 100 U/μl | A0110K |
| Ampligase® 10X Reaction Buffer | 5 ml | A1905B |
| Ampligase® DNA Ligase with Buffer | 2,500 U @ 5 U/μl | A3202K |
| Ampligase® DNA Ligase without Buffer | 10,000 U @ 5 U/μl | A3210K |
| Ampligase® DNA Ligase with Buffer | 750 U @ 5 U/μl | A32750 |
| Ampligase® DNA Ligase Kit | 1,000 U @ 5 U/μl | A8101 |
| AmpliScribe™ T7 High Yield Transcription Kit | 50 rxns | AS3107 |
| AmpliScribe T7-Flash™ Biotin-RNA Transcription Kit | 10 rxns | ASB71110 |
| AmpliScribe T7-Flash Transcription Kit | 25 Rxns | ASF3257 |
| AmpliScribe T7-Flash Transcription Kit | 50 Rxns | ASF3507 |
| ATP Solution | 25 µmol | RA02825 |
| Baseline-ZERO™ DNase | 5000 U | DB0715K |
| Biotin-16-UTP | 500 nmol | BU6105H |
| CircLigase™ ssDNA Ligase | 1000 U | CL4111K |
| CircLigase™ ssDNA Ligase | 5000 U | CL4115K |
| CircLigase™ II ssDNA Ligase | 1000 U | CL9021K |
| CircLigase™ II ssDNA Ligase | 5000 U | CL9025K |
| CopyControl™ Fosmid Autoinduction Solution | 50 ml | AIS107F |
| CopyControl Fosmid Library Production Kit | 1 kit | CCFOS110 |
| CopyControl HTP Fosmid Library Production Kit | 1 kit | CCFOS059 |
| CopyControl Induction Solution | 25 ml | CCIS125 |
| CopyCutter EPI400 Chemically Competent E.coli | 10 × 50 µl | C400CH10 |
| CopyCutter EPI400 Electrocompetent E.coli | 10 × 50 µl | C400EL10 |
| CopyCutter Induction Solution | 25 ml | CIS40025 |
| DuraScribe® T7 Transcription Kit | 10 Rxns | DS010910 |
| DuraScribe T7 Transcription Kit | 25 Rxns | DS010925 |
| End-It DNA™ End-Repair Kit | 20 Rxns | ER0720 |
| End-It DNA End-Repair Kit | 50 Rxns | ER81050 |
| EpiScript™ RNase H- Reverse Transcriptase | 10,000 Units | ERT12910K |
| EpiScript RNase H- Reverse Transcriptase | 25,000 Units | ERT12925K |
| Exonuclease I | 20,000 U | X40520K |
| Exonuclease VII | 250 U @ 10 U/μl | EN510250 |
| Exonuclease III | 25,000 U @ 200 U/μl | EX4425K |
| Exo-Minus Klenow DNA Polymerase (D355A, E357A) | 1,000 U @ 10 U/μl | KL11101K |
| EZ-Tn5™ <DHFR-1> Insertion Kit | 10 Rxns | EZI912D |
| EZ-Tn5 <KAN-2> Insertion Kit | 10 Rxns | EZI982K |
| EZ-Tn5 <KAN-2> Tnp Transposome Kit | 10 Rxns | TSM99K2 |
| EZ-Tn5 <R6Kγori/KAN-2> Insertion Kit | 10 Rxns | EZI011RK |
| EZ-Tn5 <R6Kyori /KAN-2> Tnp Transposome Kit | 10 Rxns | TSM08KR |
| EZ-Tn5 <T7/KAN-2> Promoter Insertion Kit | 10 Rxns | EZI03T7 |
| EZ-Tn5 <TET-1> Insertion Kit | 10 Rxns | EZI921T |
| EZ-Tn5 Transposase | 10 Rxns | TNP92110 |
| FailSafe™ PCR System | 1000 U | FS9901K |
| FailSafe™ PCR PreMix Selection Kit | 1 Kit | FS99060 |
| FailSafe™ PCR System | 100 U | FS99100 |
| FailSafe™ PCR System | 250 U | FS99250 |
| FailSafe™ Enzyme Mix Only | 1000 U | FSE5101K |
| FailSafe™ Enzyme Mix Only | 100 U | FSE51100 |
| FailSafe™ PCR 2X PreMix A | 2.5 ml | FSP995A |
| FailSafe™ PCR 2X PreMix B | 2.5 ml | FSP995B |
| FailSafe™ PCR 2X PreMix C | 2.5 ml | FSP995C |
| FailSafe™ PCR 2X PreMix D | 2.5 ml | FSP995D |
| FailSafe™ PCR 2X PreMix E | 2.5 ml | FSP995E |
| FailSafe™ PCR 2X PreMix F | 2.5 ml | FSP995F |
| FailSafe™ PCR 2X PreMix G | 2.5 ml | FSP995G |
| FailSafe™ PCR 2X PreMix H | 2.5 ml | FSP995H |
| FailSafe™ PCR 2X PreMix I | 2.5 ml | FSP995I |
| FailSafe™ PCR 2X PreMix J | 2.5 ml | FSP995J |
| FailSafe™ PCR 2X PreMix K | 2.5 ml | FSP995K |
| FailSafe™ PCR 2X PreMix L | 2.5 ml | FSP995L |
| Fast-Link™ DNA Ligation Kit | 100 Rxns | LK6201H |
| Fast-Link DNA Ligation Kit | 50 Rxns | LK0750H |
| FosmidMAX™ DNA Purification Kit | 1 Kit | FMAX046 |
| Hybridase™ Thermostable RNase H | 500 U @ 5 U/μl | H39500 |
| Proteinase K | 2 mL | MPRK092 |
| MasterAmp™ 10X PCR Enhancer | 10 Purifications | ME81210 |
| MasterAmp™ PCR Optimization Kit | 60 templates | MO7201 |
| MasterAmp™ 2X PCR PreMix A | 5 mL | MO7205A |
| MasterAmp™ 2X PCR PreMix B | 5 mL | MO7205B |
| MasterAmp™ 2X PCR PreMix C | 5 mL | MO7205C |
| MasterAmp™ 2X PCR PreMix D | 5 mL | MO7205D |
| MasterAmp™ 2X PCR PreMix E | 5 mL | MO7205E |
| MasterAmp™ 2X PCR PreMix F | 5 mL | MO7205F |
| MasterAmp™ 2X PCR PreMix G | 5 mL | MO7205G |
| MasterAmp™ 2X PCR PreMix H | 5 mL | MO7205H |
| MasterAmp™ 2X PCR PreMix I | 5 mL | MO7205I |
| MasterAmp™ 2X PCR PreMix J | 5 mL | MO7205J |
| MasterAmp™ 2X PCR PreMix K | 5 mL | MO7205K |
| MasterAmp™ 2X PCR PreMix L | 5 mL | MO7205L |
| MasterAmp™ Taq DNA Polymerase | 5,000 U @ 5 U/μl | Q8205K |
| MasterAmp™ Taq DNA Polymerase | 500 U @ 5 U/μl | Q82500 |
| MasterAmp™ Tth DNA Polymerase | 250 U @ 5 U/μl | TTH72250 |
| MasterPure™ Complete DNA & RNA Purification Kit | 200 Purifications | MC85200 |
| MasterPure™ Complete DNA & RNA Purification Kit | 10 Purifications | MC89010 |
| MasterPure™ DNA Purification Kit for Blood, Version II | 400 mL of Whole Blood | MB711400 |
| MasterPure™ Gram Positive DNA Purification Kit | 100 Purifications | MGP04100 |
| MasterPure™ Yeast RNA Purification Kit | 100 Purifications | MPY03100 |
| MasterPure™ Yeast DNA Purification Kit | 200 Purifications | MPY80200 |
| MaxPlax™ Lambda Packaging Extract | 10 Ext | MP5110 |
| MaxPlax Lambda Packaging Extract | 20 Ext | MP5120 |
| MaxPlax Lambda Packaging Extract | 5 Ext | MP5105 |
| MMLV High Performance Reverse Transcriptase | 25,000 U | RT80125K |
| MMLV Reverse Transcriptase 1st Strand cDNA Synthesis Kit | 50 Rxns | MM070150 |
| MPC Protein Precipitation Solution | 500 mL | MMP095H |
| NTPs: ATP, CTP, GTP, UTP Solutions | 25 umol @100mM each | RN02825 |
| OmniCleave™ Endonuclease | 50,000 U | OC7850K |
| Plasmid-Safe™ ATP-Dependent DNase | 1,000 U @ 10 U/μl | E3101K |
| Plasmid-Safe™ ATP-Dependent DNase | 10,000 U @ 10 U/μl | E3110K |
| Poly(A) Polymerase Tailing Kit | 50 rxns | PAP5104H |
| QuickExtract™ DNA Extraction Solution 1.0 | 50 mL | QE09050 |
| QuickExtract™ DNA Extraction Solution 1.0 | 5 mL | QE0905T |
| QuickExtract™ FFPE DNA Extraction Kit | 50 mL | QEF81050 |
| QuickExtract™ Plant DNA Extraction Solution | 50 mL | QEP70750 |
| QuickExtract™ RNA Extraction Kit | 50 mL | QER090150 |
| Ready-Lyse™ Lysozyme Solution | 4000000 | R1804M |
| Ready-Lyse™ Lysozyme Solution | 10000000 | R1810M |
| Rec J Exonuclease | 250 U @ 10 U/μl | RJ411250 |
| Red Cell Lysis Solution | 1200 mL | MRC0912H |
| RiboGuard™ RNase Inhibitor | 10,000 U | RG90910K |
| RiboGuard RNase Inhibitor | 2,500 U | RG90925 |
| Ribonuclease R (RNase R) | 250 | RNR07250 |
| RNA 5' Polyphosphatase | 200 | RP8092H |
| RNase A | 2 mL | MRNA092 |
| RNase I | 1000 U | N6901K |
| RNase-Free DNase I | 5,000 U @ 1 U/μl | D9905K |
| RNase-Free DNase I | 10,000 U @ 1 U/μl | D9910K |
| Sterile Nuclease-Free Water | 50 mL | W7350ML |
| T4 Polynucleotide Kinase, Cloned | 3,000 U | P0503K |
| T4 RNA Ligase 2, Deletion Mutant | 10,000 U @ 200 U/ul | LR2D11310K |
| T4 RNA Ligase 2, Deletion Mutant | 2,000 U @ 200 U/ul | LR2D1132K |
| T7 R&DNA™ Polymerase | 5,000 U @ 50 U/μl | D7P9205K |
| T7 RNA Polymerase | 50,000 U @ 1,000 U/μl | TH950K |
| TE Buffer | 70 mL | MTE0970 |
| Terminator™ 5'-Phosphate-Dependent Exonuclease | 40 U @ 1 U/μl | TER51020 |
| Tissue & Cell Lysis Solution | 600 mL | MTC096H |
| TransforMax™ EC100 Chemically Competent E.coli | 10 × 50 uL | CC02810 |
| TransforMax EC100 Electrocompetent E.coli | 10 × 100 uL | EC10010 |
| TransforMax EC100D pir+ Electrocompetent E. coli, | 5 × 100 uL | ECP09500 |
| TransforMax EC100D pir-116 Electrocompetent E. coli, | 5 × 100 uL | EC6P095H |
| TransforMax EPI300 Chemically Competent E.coli | 10 × 50 uL | C300C105 |
| TransforMax EPI300 Electrocompetent E.coli | 10 × 100 uL | EC300110 |
| TransforMax EPI300 Electrocompetent E.coli | 5 × EC300 110 | EC300150 |
| Transformax EPI300-T1R Electrocompetent E.coli | 10 × 100 uL | EC02T110 |
| TypeOne™ Restriction Inhibitor | 100 µg | TY0261H |
| Uracil N-Glycosylase | 1,000 U | UG131K |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Epicentre"> Epicentre
艾美捷科技代理Nebulabio全系列药合成、递送及点击化学产品。
北京辰辉创聚生物技术有限公司（Nebula Biotechnology Co., Ltd.）是一家专注于创新药物研发关键试剂研发的高科技企业。自2022年成立以来，已推出药物标准品系列产品、抗体药参比试剂系列产品、活性小分子系列产品。公司已和全球近50家制药公司、药物研发机构、诊断试剂产品公司建立了友好的业务合作关系。
产品列表如下，欢迎咨询。
| 产品名称 | 货号 | 规格 | CAS号 |
| trans-Cyclooct-4-en-L-Lysine (EQUATORIAL) | NBS-230715 | 500mg; 1g | 1380349-88-1 |
| PrDiAzK | NBS-230716 | 100mg; 1g | 2231405-64-2 |
| exo-BCN-Fmoc-L-Lysine (BCN) | NBS-230717 | 500mg; 1g | 1493802-76-8 |
| DiAzK | NBS-230718 | 100mg; 1g | 1253643-88-7 |
| N3-Lys | NBS-230719 | 1g; 5g | 1167421-25-1 |
| cyclopropene-L-Lysine (CP) | NBS-230720 | 500mg; 1g | 1610703-09-7 |
| endo-BCN-Fmoc-L-Lysine (BCN) | NBS-230721 | 500mg; 1g | 1493802-95-1 |
| trans-Cyclooct-2-en-L-Lysine (TCO*A) | NBS-230722 | 500mg; 1g | 1801936-26-4 |
| exo BCN-L-Lysine | NBS-230723 | 500mg; 1g | 1384100-45-1 |
| Norbonene-CH2-L-Lysine (NBO) | NBS-230724 | 500mg | 1378916-76-7 (H+) |
| rac BCN-L-Lysine | NBS-230725 | 500mg; 1g; 5g | N/A |
| trans-Cyclooct-4-en-L-Lysine (AXIAL) | NBS-230726 | 500mg; 1g | 1380349-88-1 |
| endo BCN-L-Lysine | NBS-230727 | 500mg; 1g | 1493802-96-2 / 1580501-90-1 |
| PrK -HCl-salt | NBS-230728 | 1g; 5g | 1215204-46-8 (H+) // 1428330-91-9 (HCl) |
| SCO-L-Lysine-HCO2H-salt (purity 99%) | NBS-230729 | 10mg | 1309581-49-4 |
| SCO-L-Lysine-HCO2H-salt (purity 95%) | NBS-230730 | 500mg; 1g; 5g | 1309581-49-4 |
| TCO*A-OH (AXIAL) | NBS-230731 | 100mg; 1g | 1414375-00-0 |
| Me-Tet-PEG2-NH2 | NBS-230732 | 100mg; 500mg | N/A |
| Coumarin-PEG4-Tetrazine | NBS-230734 | 1mg; 5mg | N/A |
| Coumarin-C2-exoBCN | NBS-230735 | 1mg; 5mg | 2488174-17-8 |
| Coumarin-C2-TCO (axial) | NBS-230736 | 1mg; 5mg | 2488174-16-7 |
| (E)-cyclooctene doxorubicin conjugate (axial) | NBS-230738 | 10mg | 1438387-95-1 |
| SCO-NHS carbonate | NBS-230739 | 100mg; 1g | N/A |
| exo-BCN-NHS carbonate | NBS-230740 | 500mg; 1g | 1493802-77-9 |
| endo-BCN-NHS carbonate | NBS-230741 | 500mg; 1g | 1426827-79-3 |
| TCO4-NHS carbonate (EQUATORIAL) | NBS-230742 | 500mg; 1g | 1191901-33-3 |
| TCO4-NHS carbonate (AXIAL) | NBS-230743 | 500mg; 1g | 1191901-33-3 |
| TCO*-NHS carbonate (EQUATORIAL) | NBS-230744 | 500mg; 1g | 1610931-22-0 |
| TCO*-NHS carbonate (AXIAL) | NBS-230745 | 100mg; 1g | 1610931-22-0 |
| Tetrazine-Amine-TFA-salt | NBS-230746 | 100mg; 500mg | 1092689-33-2 |
| TCO*E-active ester (p-NPC, equatorial) | NBS-230747 | 100mg; 1g | 1580501-97-8 |
| exo BCN-OH | NBS-230850 | 500mg; 1g | 1263291-41-3 |
| SCO-active ester (p-NPE) | NBS-230851 | 500mg; 1g | 1309581-51-8 |
| SCO-OH | NBS-230852 | 500mg; 1g | 29916-92-5 |
| endo BCN-OH | NBS-230853 | 500mg; 1g | 1263166-90-0 |
| Aminopentyl-Tetrazine-HCl-salt | NBS-230854 | 100mg; 500mg | N/A |
| (E)-cyclooctene doxorubicin conjugate (EQUATORIAL) | NBS-230855 | 10mg | 1438387-96-2 |
| (E)-cyclooct-4-enol / equatorial-TCO / E | NBS-230856 | 100mg; 1g | 39637-79-1 |
| (E)-cyclooct-4-en active ester / TCO/E- active ester (p-NPE) (EQUATORIAL) | NBS-230857 | 100mg; 1g | 1354323-64-0 |
| (E)-cyclooct-4-en active ester / TCO4 / A- active ester (p-NPE) (AXIAL) | NBS-230858 | 100mg; 1g | 1438415-89-4 |
| (E)-cyclooct-4-enol / axial -TCO4 / A | NBS-230859 | 100mg; 1g | 39637-78-0 |
| Tetrazine active ester (Tetrazine-NHS) | NBS-230860 | 100mg; 500mg | 1384271-41-3 |
| Aminopropyl-Tetrazine-HCl-salt | NBS-230861 | 100mg; 500mg | 1146968-37-7 (H+) |
| N-Trifluoro-Acetylpropargylamine | NBS-230862 | 1g; 5g | 14719-21-2 |
| Methyl-Tetrazine-Amine- HCO2H-salt | NBS-230863 | 100mg; 500mg | 1345955-28-3 (H) |
| Tetrazine-Amine-HCO2H-salt | NBS-230864 | 100mg; 500mg | 1092689-33-2 (H) |
| TCO*A-OH (EQUATORIAL) | NBS-230865 | 100mg; 1g | 93301-75-8 |
| BCN-3,5-diene-9-methanol | NBS-230866 | 500mg; 1g | 1072439-47-4 |
| TCO*A-active ester (p-NPE) | NBS-230867 | 100mg; 1g | 1580501-97-8 |
| exo BCN-active ester (p-NPE) | NBS-230868 | 500mg | 1380006-72-3 |
| endo BCN-active ester (p-NPE) | NBS-230869 | 500mg; 1g | 1263166-91-1 |
| 12-Azidododecanoic acid | NBS-230876 | 100mg | 80667-36-3 |
| EdU | NBS-230877 | 100mg | 61135-33-9 |
| Pr-DiAz-OH | NBS-230878 | 100mg; 500mg | 1450754-41-2 |
| Pr-DiAz-NHSC | NBS-230879 | 100mg; 500mg | 2488239-96-7 |
| DiAz-NHSE | NBS-230880 | 100mg; 500mg | 1239017-80-1 |
| Pr-DiAz-NHSE | NBS-230881 | 100mg; 500mg | 2012552-32-6 |
| Pr-DiAz-COOH | NBS-230882 | 100mg; 500mg | 1450754-37-6 |
| Pr-DiAz-NH2 | NBS-230883 | 100mg; 500mg | 1450752-97-2 |
| Coumarin-PEG8-Tetrazine | NBS-230884 | 1mg; 5mg | N/A |
| Coumarin-PEG3-TCO* (AXIAL) | NBS-230885 | 1mg; 5mg | 2488319-02-2 |
| Coumarin-PEG7-TCO* (AXIAL) | NBS-230886 | 1mg; 5mg | N/A |
| Coumarin-PEG2-TCO* (AXIAL) | NBS-230891 | 1mg; 5mg | 2488174-19-0 |
| Coumarin-PEG2-exoBCN | NBS-230892 | 1mg; 5mg | 2488174-18-9 |
| Coumarin-PEG2-SCO | NBS-230893 | 1mg; 5mg | 2488239-94-5 |
| Coumarin-PEG2-endoBCN | NBS-230894 | 1mg; 5mg | 2488174-18-9 |
| Biotin-PEG3-CoenzymeA | NBS-230895 | 100µg; 1mg | N/A |
| Bis-Cyano-PEG9 | NBS-230896 | 100mg; 500mg | 41263-81-4 |
| Bis-Cyano-PEG5 | NBS-230897 | 100mg; 500mg | 41263-79-0 |
| Bis-Cyano-PEG4 | NBS-230898 | 100mg; 500mg | 57741-46-5 |
| N3-PEG8-t-butyl ester | NBS-230899 | 100mg; 1g | 1623791-99-0 |
| N3-PEG5-t-butyl ester | NBS-230900 | 100mg; 1g | 1415800-41-7 |
| N3-PEG4-t-butyl ester | NBS-230901 | 100mg; 1g | 581066-04-8 |
| N3-PEG3-t-butyl ester | NBS-230902 | 100mg; 1g | 252881-73-5 |
| Boc-N-Amido-PEG7-N3 | NBS-230903 | 100mg; 500mg | 206265-96-5 |
| Boc-N-Amido-PEG3-N3 | NBS-230904 | 100mg; 500mg | 642091-68-7 |
| Boc-N-Amido-PEG2-N3 | NBS-230905 | 100mg; 500mg | 950683-55-3 |
| Boc-N-Amido-PEG4-Alkyne | NBS-230906 | 100mg; 500mg | 1219810-90-8 |
| Boc-N-Amido-PEG3-Alkyne | NBS-230907 | 100mg; 500mg | 1333880-60-6 |
| Fluorescent-PEG8-Me-Tet | NBS-230908 | 5mg; 25mg | N/A |
| Fluorescent-PEG4-Me-Tet | NBS-230909 | 5mg; 25mg | N/A |
| Fluorescent-PEG3-Me-Tet | NBS-230910 | 5mg; 25mg | N/A |
| TAMRA-PEG8-Alkyne | NBS-230911 | 5mg; 25mg | N/A |
| TAMRA-PEG4-Alkyne | NBS-230912 | 5mg; 25mg | 1225057-68-0 |
| TAMRA-PEG3-Alkyne | NBS-230913 | 5mg; 25mg | N/A |
| TAMRA-PEG7-N3 | NBS-230914 | 5mg; 25mg | N/A |
| TAMRA-PEG3-N3 | NBS-230915 | 5mg; 25mg | 1228100-59-1 |
| TAMRA-PEG2-N3 | NBS-230916 | 5mg; 25mg | N/A |
| TAMRA-PEG8-COOH | NBS-230917 | 5mg; 25mg | N/A |
| TAMRA-PEG4-COOH | NBS-230918 | 5mg; 25mg | N/A |
| TAMRA-PEG3-COOH | NBS-230919 | 5mg; 25mg | N/A |
| TAMRA-PEG8-NHS | NBS-230920 | 5mg; 25mg | 2067281-44-9 |
| TAMRA-PEG4-NHS | NBS-230921 | 5mg; 25mg | N/A |
| TAMRA-PEG3-NHS | NBS-230922 | 5mg; 25mg | N/A |
| TAMRA-PEG7-Maleimide | NBS-230923 | 5mg; 25mg | N/A |
| TAMRA-PEG3-Maleimide | NBS-230924 | 5mg; 25mg | N/A |
| TAMRA-PEG2-Maleimide | NBS-230925 | 5mg; 25mg | N/A |
| TAMRA-PEG7-NH2 | NBS-230926 | 5mg; 25mg | N/A |
| TAMRA-PEG3-NH2 | NBS-230927 | 5mg; 25mg | N/A |
| TAMRA-PEG2-NH2 | NBS-230928 | 5mg; 25mg | 1425379-69-6 |
| Me-Tet-PEG8-NHBoc | NBS-230929 | 100mg; 500mg | 2143968-21-0 |
| Me-Tet-PEG4-NHBoc | NBS-230930 | 100mg; 500mg | 2143955-71-7 |
| Me-Tet-PEG3-NHBoc | NBS-230931 | 100mg; 500mg | 2141976-32-9 |
| Biotin-PEG8-Me-Tet | NBS-230932 | 100mg; 500mg | 2143958-82-9 |
| Biotin-PEG4-Me-Tet | NBS-230933 | 100mg; 500mg | 1962919-31-8 |
| Biotin-PEG3-Me-Tet | NBS-230934 | 100mg; 500mg | 2143968-06-1 |
| Me-Tet-PEG9-COOH | NBS-230935 | 100mg; 500mg | 2143964-70-7 |
| Me-Tet-PEG5-COOH | NBS-230936 | 100mg; 500mg | 2143964-72-9 |
| Me-Tet-PEG4-COOH | NBS-230937 | 100mg; 500mg | 2141976-30-7 |
| Me-Tet-PEG9-NHS | NBS-230938 | 100mg; 500mg | 2143955-78-4 |
| Me-Tet-PEG5-NHS | NBS-230939 | 100mg; 500mg | 2096446-25-0 |
| Me-Tet-PEG4-NHS | NBS-230940 | 100mg; 500mg | 2143968-22-1 |
| Me-Tet-PEG8-Maleimide | NBS-230941 | 100mg; 500mg | 2143968-05-0 |
| Me-Tet-PEG4-Maleimide | NBS-230942 | 100mg; 500mg | 1715913-76-0 |
| Me-Tet-PEG3-Maleimide | NBS-230943 | 100mg; 500mg | 2141976-31-8 |
| Me-Tet-PEG8-NH2-HCl salt | NBS-230944 | 100mg; 500mg | 2143958-58-9 (H+) |
| Me-Tet-PEG4-NH2 | NBS-230945 | 100mg; 500mg | 2055646-21-2 |
| Me-Tet-PEG3-NH2 | NBS-230946 | 100mg; 500mg | 2141976-28-3 |
| Biotin-PEG8-Alkyne | NBS-230947 | 100mg; 500mg | 2143968-80-1 |
| Biotin-PEG4-Alkyne | NBS-230948 | 100mg; 500mg | 1262681-31-1 |
| Biotin-PEG3-Alkyne | NBS-230949 | 100mg; 500mg | 1421701-68-9 |
| Biotin-PEG7-N3 | NBS-230950 | 100mg; 500mg | 1334172-75-6 |
| Biotin-PEG3-N3 | NBS-230951 | 100mg; 500mg | 875770-34-6 |
| Biotin-PEG2-N3 | NBS-230952 | 100mg; 500mg | 945633-30-7 |
| Biotin-PEG8-COOH | NBS-230953 | 100mg; 500mg | 2143964-62-7 |
| Biotin-PEG4-COOH | NBS-230954 | 100mg; 500mg | 721431-18-1 |
| Biotin-PEG3-COOH | NBS-230955 | 100mg; 500mg | 252881-76-8 |
| Biotin-PEG8-NHS | NBS-230956 | 100mg; 500mg | 2143968-03-8 |
| Biotin-PEG4-NHS | NBS-230957 | 100mg; 500mg | 459426-22-3 |
| Biotin-PEG3-NHS | NBS-230958 | 100mg; 500mg | 1253286-56-4 |
| Biotin-PEG7-Maleimide | NBS-230959 | 100mg; 500mg | 1898221-65-2 |
| Biotin-PEG3-Maleimide | NBS-230960 | 100mg; 500mg | 1431618-70-0 |
| Biotin-PEG2-Maleimide | NBS-230961 | 100mg; 500mg | 305372-39-8 |
| Biotin-PEG7-NH2 | NBS-230962 | 100mg; 500mg | 1334172-76-7 |
| Biotin-PEG3-NH2 | NBS-230963 | 100mg; 500mg | 359860-27-8 |
| Biotin-PEG2-NH2 | NBS-230964 | 100mg; 500mg | 138529-46-1 |
| TCO4-PEG8-COOH | NBS-230965 | 100mg; 500mg | N/A |
| TCO*-PEG8-COOH | NBS-230966 | 100mg; 500mg | N/A |
| TCO*-PEG4-COOH | NBS-230967 | 100mg; 500mg | N/A |
| TCO4-PEG4-COOH | NBS-230968 | 100mg; 500mg | 1802913-21-8 |
| TCO4-PEG3-COOH | NBS-230969 | 100mg; 500mg | 2141981-86-2 |
| TCO*-PEG3-COOH | NBS-230970 | 100mg; 500mg | N/A |
| TCO*-PEG8-NHS | NBS-230971 | 100mg; 500mg | N/A |
| TCO4-PEG8-NHS | NBS-230972 | 100mg; 500mg | N/A |
| TCO4-PEG4-NHS | NBS-230973 | 100mg; 500mg | 1621096-79-4 |
| TCO*-PEG4-NHS | NBS-230974 | 100mg; 500mg | N/A |
| TCO*-PEG3-NHS | NBS-230975 | 100mg; 500mg | N/A |
| TCO4-PEG3-NHS | NBS-230976 | 100mg; 500mg | 2141981-88-4 |
| TCO*-PEG7-Maleimide | NBS-230977 | 100mg; 500mg | N/A |
| TCO*-PEG3-Maleimide | NBS-230978 | 100mg; 500mg | 2392039-23-3 |
| TCO*-PEG2-Maleimide | NBS-230979 | 100mg; 500mg | N/A |
| TCO4-PEG7-Maleimide | NBS-230980 | 100mg; 500mg | N/A |
| TCO4-PEG3-Maleimide | NBS-230981 | 100mg; 500mg | 1914971-04-2 |
| TCO4-PEG2-Maleimide | NBS-230982 | 100mg; 500mg | 2141981-85-1 |
| TCO*-PEG2-NH2 | NBS-230983 | 100mg; 500mg | N/A |
| TCO*-PEG3-NH2 | NBS-230984 | 100mg; 500mg | N/A |
| TCO*-PEG7-NH2 | NBS-230985 | 100mg; 500mg | N/A |
| TCO4-PEG7-NH2 | NBS-230986 | 100mg; 500mg | N/A |
| TCO4-PEG3-NH2 | NBS-230987 | 100mg; 500mg | 1800507-93-0 |
| TCO4-PEG2-NH2 | NBS-230988 | 100mg; 500mg | N/A |
| SCO-PEG7-Maleimide | NBS-230989 | 100mg; 500mg | 2143968-81-2 |
| SCO-PEG3-Maleimide | NBS-230990 | 100mg; 500mg | 2141976-35-2 |
| SCO-PEG2-Maleimide | NBS-230991 | 100mg; 500mg | 2141976-23-8 |
| BCN-exo-PEG7-Maleimide | NBS-230992 | 100mg; 500mg | N/A |
| BCN-exo-PEG3-Maleimide | NBS-230993 | 100mg; 500mg | N/A |
| BCN-exo-PEG2-Maleimide | NBS-230994 | 100mg; 500mg | 2141976-22-7 |
| BCN-endo-PEG7-Maleimide | NBS-230995 | 100mg; 500mg | N/A |
| BCN-endo-PEG3-Maleimide | NBS-230996 | 100mg; 500mg | 2141976-33-0 |
| BCN-endo-PEG2-Maleimide | NBS-230997 | 100mg; 500mg | N/A |
| BCN-exo-PEG8-COOH | NBS-230998 | 100mg; 500mg | N/A |
| BCN-exo-PEG4-COOH | NBS-230999 | 100mg; 500mg | 1421932-54-8 |
| BCN-exo-PEG3-COOH | NBS-231000 | 100mg; 500mg | 1807501-82-1 |
| BCN-exo-PEG8-NHS | NBS-231001 | 100mg; 500mg | N/A |
| BCN-exo-PEG4-NHS | NBS-231002 | 100mg; 500mg | N/A |
| BCN-exo-PEG3-NHS | NBS-231003 | 100mg; 500mg | 2101206-94-2 |
| BCN-endo-PEG3-NHS | NBS-231004 | 100mg; 500mg | 2101206-94-2 |
| BCN-endo-PEG4-NHS | NBS-231005 | 100mg; 500mg | 1702356-19-1 |
| BCN-endo-PEG8-NHS | NBS-231006 | 100mg; 500mg | 1608140-48-2 |
| BCN-endo-PEG8-COOH | NBS-231007 | 100mg; 500mg | N/A |
| BCN-endo-PEG4-COOH | NBS-231008 | 100mg; 500mg | 1881221-47-1 |
| BCN-endo-PEG3-COOH | NBS-231009 | 100mg; 500mg | 1807501-82-1 |
| SCO-PEG3-COOH | NBS-231010 | 100mg; 500mg | 2141976-36-3 |
| SCO-PEG4-COOH | NBS-231011 | 100mg; 500mg | 2141976-27-2 |
| SCO-PEG8-COOH | NBS-231012 | 100mg; 500mg | 2143968-79-8 |
| SCO-PEG8-NHS | NBS-231013 | 100mg; 500mg | 2143968-68-5 |
| SCO-PEG4-NHS | NBS-231014 | 100mg; 500mg | 2141976-26-1 |
| SCO-PEG3-NHS | NBS-231015 | 100mg; 500mg | 2141976-25-0 |
| SCO-PEG7-NH2 | NBS-231016 | 100mg; 500mg | 2141976-35-2 |
| SCO-PEG3-NH2 | NBS-231017 | 100mg; 500mg | 2141976-29-4 |
| SCO-PEG2-NH2 | NBS-231018 | 100mg; 500mg | 2141976-34-1 |
| BCN-exo-PEG2-NH2 | NBS-231019 | 100mg; 500mg | 1357379-13-5 |
| BCN-exo-PEG3-NH2 | NBS-231020 | 100mg; 500mg | 1841134-72-2 |
| BCN-exo-PEG7-NH2 | NBS-231021 | 100mg; 500mg | 2143968-34-5 |
| BCN-endo-PEG7-NH2 | NBS-231022 | 100mg; 500mg | 2143968-34-5 |
| BCN-endo-PEG3-NH2 | NBS-231023 | 100mg; 500mg | 1883512-27-3 |
| BCN-endo-PEG2-NH2 | NBS-231024 | 100mg; 500mg | 1263166-93-3 |
| PEG-12 | NBS-231025 | 1g; 10g; bulk | 6790-09-6 |
| PEG-11 | NBS-231026 | 1g; 10g; bulk | 6809-70-7 |
| PEG-10 | NBS-231027 | 1g; 10g; bulk | 5579-66-8 |
| PEG-9 | NBS-231028 | 1g; 10g; bulk | 3386-18-3 |
| PEG-8 | NBS-231029 | 1g; 10g; 100g; 1kg; bulk | 5117-19-1 |
| Alkyne-PEG2-TCA | NBS-231030 | 100mg | 1281695-03-1 |
| Azido-PEG2-TCA | NBS-231031 | 100mg | 1281695-02-0 |
| Alkyne-PEG2-CM | NBS-231032 | 100mg | 1281695-01-9 |
| Azido-PEG2-CM | NBS-231033 | 100mg | 1281695-00-8 |
| Alkyne-PEG2 | NBS-231034 | 100mg | 7218-43-1 |
| Azido-PEG1 | NBS-231035 | 100mg | 139115-90-5 |
| 2-Methyl-Glycerol | NBS-231036 | 10g; 100g | 25245-58-3 |
| 2-Stearoyl glycerol | NBS-231037 | 20mg; 100mg | 621-61-4 |
| 2-Palmitoyl glycerol | NBS-231038 | 20mg; 100mg | 23470-00-0 |
| 2-Myristoyl glycerol | NBS-231039 | 20mg; 100mg | 3443-83-2 |
| 2-Lauroyl glycerol | NBS-231040 | 20mg; 100mg | 1678-45-1 |
| 2-Linoleoyl glycerol | NBS-231041 | 100 mmol solution in ACN | 3443-82-1 |
| 2-Oleoyl-glycerol | NBS-231042 | 10mg; 100mg | 3443-84-3 |
| SH-6 | NBS-231043 | 1mg; 5mg | 701976-55-8 |
| SH-5 | NBS-231044 | 1mg; 5mg | 701976-54-7 |
| Ins(345)P3*3Na | NBS-231045 | 1mg | 112791-62-5 (H) / 911105-38-9 (6 Na) |
| Ins(1)P*2K | NBS-231046 | 5mg | 313263-16-0 / 15421-51-9 (H) |
| myo-Inositol-trispyrophosphate | NBS-231047 | 100mg | 623552-11-4 / 802590-64-3 / 23103-35-7 |
| Ins(123456)P6 | NBS-231048 | 5g; 25g | 83-86-3 / 14306-25-3 (sodium salt) |
| Ins(23456)P5*10Na | NBS-231049 | 1mg | 109526-12-7 (8Na) / 25663-09-6 (H+) |
| Ins(13456)P5*10Na | NBS-231050 | 1mg | 20298-95-7 (H+) |
| Ins(12456)P5*10Na | NBS-231051 | 1mg | 183075-26-5 / 20298-94-6 (H+) |
| Ins(12356)P5*10Na | NBS-231052 | 1mg | 109526-12-7 (8Na) / 25663-09-6 (H+) |
| Ins(12345)P5*10Na | NBS-231053 | 1mg | 183075-27-6 / 20298-96-8 (H+) |
| Ins(1345)P4*8Na | NBS-231054 | 1mg | 135269-51-1 (H+: 99610-76-1) |
| Ins(136)P3*6Na | NBS-231055 | 1mg | 93133-75-6 (H) |
| Ins(134)P3*6K | NBS-231056 | 1mg; 5mg | 140385-74-6 / 98102-63-7 (H) / 145920-23-6 (6Na) |
| Ins(345)P3*3K | NBS-231057 | 1mg | 348128-32-5 / 112791-62-5 (H) / 348128-47-2 (x*K) |
| Ins(145)P3*6K | NBS-231058 | 5mg | 103476-24-0 / 85166-31-0 (H) |
| Ins(145)P3*3Li | NBS-231059 | 5mg | 129828-69-9 / 85166-31-0 (H) |
| Ins(145)P3*6Na | NBS-231060 | 5mg | 108340-81-4 / 85166-31-0 (H) |
| Ins(135)P3*6Na | NBS-231061 | 1mg | N/A |
| Ins(1245)P4*8Na | NBS-231062 | 1mg | 170715-18-1 (H+: 117142-45-7) |
| Bt3-Ins(356)P3 / PM | NBS-231063 | 1 µmol | N/A |
| Bt3-Ins(346)P3 / PM | NBS-231064 | 1 µmol | 503158-16-5 |
| Bt3-Ins(146)P3 / PM | NBS-231065 | 1 µmol | 503158-17-6 |
| Bt3-Ins(135)P3 / PM | NBS-231066 | 1 µmol | 503158-15-4 |
| Bt2-Ins(3456)P4 / PM | NBS-231067 | 1 µmol | 1233512-98-5 |
| Bt2-Ins(1456)P4 / PM | NBS-231068 | 1 µmol | N/A |
| Bt2-Ins(1345)P4 / PM | NBS-231069 | 1 µmol | 503158-20-1 |
| Bt2-Ins(1356)P4 / AM | NBS-231070 | 1 µmol | 164199-43-3 |
| Bt3-Ins(356)P3 / AM | NBS-231071 | 1 µmol | 164199-42-2 |
| Bt3-Ins(346)P3 / AM | NBS-231072 | 1 µmol | 431900-03-7 |
| Bt3-Ins(146)P3 / AM | NBS-231073 | 1 µmol | 431900-02-6 |
| Bt3-Ins(134)P3 / AM | NBS-231074 | 1 µmol | 205247-51-4 |
| Bt3-Ins(136)P3 / AM | NBS-231075 | 1 µmol | N/A |
| Bt3-Ins(135)P3 / AM | NBS-231076 | 1 µmol | 1258008-22-8 |
| Bt3-Ins(145)P3 / AM | NBS-231077 | 1 µmol | 164007-69-6 (196954-45-7) |
| caged-Ins(145)P3 / PM | NBS-231078 | 10 * 10 µg | 1009832-82-9 |
| caged-Ins(145)P3 / PM | NBS-231079 | 100 µg | 1009832-82-9 |
| caged-Ins(145)P3O6 | NBS-231080 | 100 µg | 887903-55-1 (H+) |
| caged-Ins(145)P3 P4 | NBS-231081 | 100 µg | 119147-20-5 / 132204-31-0 |
| PtdIns(345)P3 | NBS-231082 | 1mg | 165689-82-7 |
| PtdIns(45)P2 | NBS-231083 | 1mg | 120595-88-2 / 213596-15-7 |
| PtdIns(34)P2 | NBS-231084 | 1mg | 165883-85-2 |
| PtdIns(5)P | NBS-231085 | 1mg | 291527-75-8 |
| PtdIns(4)P | NBS-231086 | 1mg | 57606-15-2 |
| PtdIns(3)P | NBS-231087 | 1mg | 165689-81-6 |
| PtdIns(1)P | NBS-231088 | 1mg | 62742-56-7 / 28366-80-5 |
| D-myo-Inositol-1,2-O-cyclohexylidene | NBS-231089 | 1g | 55123-25-6 (rac: 6763-47-9) |
| 23:45-diisopropylidene-myo-Inositol | NBS-231090 | 1g | 211294-75-6 |
| 12:56- diisopropylidene-myo-Inositol | NBS-231091 | 1g | 211294-79-0 |
| D-myo-Inositol-2,3-O-cyclohexylidene | NBS-231092 | 1g | 57029-87-5 |
| 2,3:4,5-Di-O-Iso-1,6-Di-O-Benzyl-Ins | NBS-231093 | 1g | 131233-62-0 / 1266500-90-6 |
| 1,2:5,6-Di-O-Iso-3,4-Di-O-Benzyl-Ins | NBS-231094 | 1g | 131233-62-0 / 1266500-90-6 |
| DEAC-dUTP | NBS-231095 | 25 nmol; 100 nmol | N/A |
| 35-PAPS-TEA | NBS-231096 | 5mg | 936827-87-1 |
| ACPPS-TEA | NBS-231097 | 5mg | 102029-54-9 / 62230-90-4 |
| 25-PAPS-Li | NBS-231098 | 5mg | 62230-89-1 / 102029-54-9 |
| 35-PAPS-Li (CAS: 102029-54-9) | NBS-231099 | 5mg | 102029-54-9 / 482-67-7 (H+) |
| EdUTP-TEA | NBS-231100 | 1mg | 1191275-46-3 |
| EdUTP | NBS-231101 | 1mg | 111289-87-3 |
| 2'-PAP | NBS-231102 | 10mg; 50mg | 3805-37-6 |
| 2'-PAP-Na | NBS-231103 | 10mg; 50mg | 108347-94-0 |
| 3'-PAP-Na | NBS-231104 | 10mg; 50mg | 75431-54-8 |
| 3'-PAP | NBS-231105 | 10mg; 50mg | 1053-73-2 |
| Vancomycin hexapeptide | NBS-231106 | 5mg; 10mg | 115236-65-2 |
| Didechloro Vancomycin | NBS-231107 | 20mg; 100mg | 98510-30-6 |
| Vancomycin Impurity A | NBS-231108 | 20mg; 100mg | 91700-98-0 |
| Vancomycin Impurity D | NBS-231109 | 5mg; 10mg | 101485-50-1 |
| Vancomycin Impurity C | NBS-231110 | 5mg; 10mg | 82198-76-3 |
| Vancomycin Impurity B | NBS-231111 | 20mg; 100mg | 55598-85-1 |
| INO-4995 | NBS-231112 | 1mg; 10mg | 868171-91-9 |
| Podophyllotoxin Derivate | NBS-231113 | 100mg | 6559-91-7 |
| Podophyllotoxin Derivate | NBS-231114 | 10mg | 117507-84-3 |
| Clopidogrel Impurity 4 | NBS-231115 | 100mg | 144457-43-2 |
| Gestodene Impurity E | NBS-231116 | 1mg; 10mg | N/A |
| Fidaxomicin Metabolite OP-1118 | NBS-231117 | 1mg; 10mg | 1030825-28-5 |
| Prasugrel metabolite M6-d3 (stabilzed) | NBS-231118 | 1mg | 1234692-58-0 (without d3) |
| Prasugrel metabolite M6 | NBS-231119 | 10mg | 947530-51-0 |
| Clopidogrel Impurity C | NBS-231120 | 10mg | 1346605-15-9 |
| Clopidogrel Impurity 3 | NBS-231121 | 10mg | 141109-18-4 |
| Prasugrel active metabolite M3 HCl (stabilized) | NBS-231122 | 1mg; 5mg | 1287383-06-5 |
| Fidaxomicin-d7 | NBS-231123 | 1mg; 10mg | 873857-62-6 (unlabeled) |
| Methyl 4-(2-hydroxyethyl)benzoate-13C6,2D (Ring-13C6,Ethyl-1,2-D2) | NBS-231124 | 10mg | N/A |
| Anthracene 13C6 | NBS-231125 | 10mg | 189811-60-7 |
| Phenanthrene 13C6 | NBS-231126 | 10mg | 1189955-53-0 |
| Naphthalene 13C10 | NBS-231127 | 10mg | 219526-41-7 |
| Naphthalene 13C6 | NBS-231128 | 10mg | 1192501-11-3 |
| Prasugrel active metabolite M3-d3 (stabilzed) | NBS-231129 | 1mg; 5mg | 1619986-66-1 / 1226870-93-4 (without HCl) |
| 2-Cyanoethyl N,N-diisopropylchlorophosphoramidite | NBS-231130 | 10g | 89992-70-1 |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. bis(2-cyanoethyl) ester | NBS-231131 | 5g | 102690-88-0 |
| Phosphoramidous acid, N,N-bis(1-methylethyl)-, bis(phenylmethyl) ester | NBS-231132 | 10g | 108549-23-1 |
| Phosphorodiamidous acid. N.N.N'.N'-tetrakis(1-methylethyl)-. phenylmethyl ester | NBS-231133 | 1g | 108549-21-9 |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. 2-cyanoethyl [1-(2-nitrophenyl)ethyl] ester) | NBS-231134 | 100mg | 461425-49-0 |
| Dichloro N,N-Diisopropylphosphoramidite | NBS-231135 | 10g | 921-26-6 |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. bis(9H-fluoren-9-ylmethyl) ester | NBS-231136 | 1g; 5g; 10g | 197709-11-8 |
| Di-tert-butyl chloromethyl phosphate | NBS-231137 | 1g | 229625-50-7 |
| Di-benzyl chloromethyl phosphate | NBS-231138 | 1g | 258516-84-6 |
| Ethyl 2-methyl-3-(trimethylsilyl)cycloprop-2-ene-1-carboxylate | NBS-231139 | 1g | 33002-26-5 |
| NOTA-Evans Blue / NEB | NBS-231140 | 1mg; 10mg | N/A |
| CoA-Cy5 | NBS-231141 | 1mg | N/A |
| CoA-Cy3 | NBS-231142 | 1mg | N/A |
| TMe-OHB-DAZA | NBS-231143 | 1mg; 10mg | 2241024-76-8 |
| NEmo2E | NBS-231144 | 10 µL; 50 µL | N/A |
| NEmo1 | NBS-231145 | 10 µL; 50 µL | N/A |
| Phycocyanobilin-PCB | NBS-231146 | 10mg; 25mg | 20298-86-6 |
| D-Serine-O-phosphate | NBS-231147 | 1g; 5g | 73913-63-0 |
| Ph-CCA-NH2 | NBS-231148 | 250mg | 129179-92-6 |
| Menaquinone 8 / MK 8:8 | NBS-231149 | 100 µg; 500 µg | 523-38-6 |
| Allyl-Maleimide | NBS-231150 | 100mg ; 500mg | 2973-17-3 |
| Nor-cisapride Derivative | NBS-231151 | 100mg; 1g | N/A |
| AlK-L-Lysine-HCl-salt | NBS-231152 | 2g; 5g | 6298-03-9 (H+) // 147529-99-5 (HCl) |
| 4-methyl-2,2-bis(trifluoromethyl)oxazolidin-5-one | NBS-231153 | 1g | 6458-31-7 |
| 3-(5-oxo-2,2-bis(trifluoromethyl)oxazolidin-4-yl)propanoic acid | NBS-231154 | 1g | 6458-51-1 |
| 7-(diethylamino)-4-(hydroxymethyl)-coumarin / DEACM | NBS-231155 | 100mg | 54711-38-5 |
| 3-bromo-4-methyl-7-(diethylamino)-coumarin | NBS-231156 | 100mg | 92295-93-7 |
| Xanthohumol | NBS-231157 | 10mg; 50mg | 6754-58-1 |
| IEPOX 4 | NBS-231158 | 5mg | 1189798-08-0 |
| IEPOX 3 | NBS-231159 | 5mg | 1189798-08-0 |
| 2-C-Methyl-L-Threitol | NBS-231160 | 5mg | 93921-84-7 |
| 2-C-Methyl-D-Threitol | NBS-231161 | 5mg | 310887-92-4 |
| 2-C-Methyl-L-Erythritol | NBS-231162 | 5mg | 93921-83-6 |
| 2-C-Methyl-D-Erythritol | NBS-231163 | 5mg | 58698-37-6 |
| 3-Amino-7-(diethylamino)-coumarine | NBS-231164 | 100mg; 500mg | 817638-67-8 |
| Chloromethylpropionate | NBS-231165 | 1g; 5g | 5402-53-9 |
| 2-(2-fluoro-2-methylpropoxy)-2-methylpropan-1-ol | NBS-231166 | 1g; 10g | 1823357-87-4 |
| 1,4-Di-butyryl-23:56-diisopropylidene-myo-Inositol | NBS-231167 | 0.5g; 1g | 1620222-02-7 |
| 3,6-Di-butyryl-12:45-diisopropylidene-myo-Inositol | NBS-231168 | 0.5g; 1g | 1307298-34-5 |
| Y-27632 | NBS-231169 | 50mg | 146986-50-7 |
| H-1152 | NBS-231170 | 10mg | 45146-2-58-1 |
| 3,4,5,6-Tetra-O-Benzyl-Ins | NBS-231171 | 1g | 24558-77-8 |
| 1,4,5,6-Tetra-O-Benzyl-Ins | NBS-231172 | 1g | 26276-99-3 |
| 2,5-Anhydro-6-azido-6-deoxy-1,3-O-isopropylidene-D-glucitol | NBS-231173 | 1g、5g、10g、25g、Bulk | N/A |
| 4-Azido-4-deoxy-1,6:2,3-dianhydro-β-D-mannopyranose | NBS-231174 | 1g、5g、10g、25g、Bulk | N/A |
| Methyl-3,6-anhydro-7-azido-2,7-dideoxy-4,5-O-isopropylidene-D-alloheptonate | NBS-231175 | 1g、5g、10g、25g、Bulk | N/A |
| 1,4-Anhydro-3-azido-2-O-benzoyl-3-deoxy-D-xylitol | NBS-231176 | 1g、5g、10g、25g、Bulk | N/A |
| 1,4-Anhydro-2-azido-3-O-benzoyl-2-deoxy-D-arabitol | NBS-231177 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,4;3,6-dianhydro-D-glucitol | NBS-231178 | 1g、5g、10g、25g、Bulk | N/A |
| 6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-D-galactopyranose | NBS-231179 | 1g、5g、10g、25g、Bulk | N/A |
| 6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-L-galactopyranose | NBS-231180 | 1g、5g、10g、25g、Bulk | N/A |
| DIBMA free acid | NBS-231181 | 1g、5g、10g、25g、Bulk | N/A |
| DIBMA monosodium salt | NBS-231182 | 1g、5g、10g、25g、Bulk | N/A |
| Glyco-DIBMA | NBS-231183 | 1g、5g、10g、25g、Bulk | N/A |
| n-Octyl α-D-glucopyranoside | NBS-231184 | 1g、5g、10g、25g、Bulk | 29781-80-4 |
| HECAMEG | NBS-231185 | 1g、5g、10g、25g、Bulk | 115457-83-5 |
| n-Hexyl β-D-glucopyranoside | NBS-231186 | 1g、5g、10g、25g、Bulk | 59080-45-4 |
| n-Heptyl β-D-glucopyranoside | NBS-231187 | 1g、5g、10g、25g、Bulk | 78617-12-6 |
| n-Octyl β-D-glucopyranoside | NBS-231188 | 1g、5g、10g、25g、Bulk | 29836-26-8 |
| n-Octyl β-D-glucopyranoside | NBS-231189 | 1g、5g、10g、25g、Bulk | 29836-26-8 |
| n-Nonyl β-D-glucopyranoside | NBS-231190 | 1g、5g、10g、25g、Bulk | 69984-73-2 |
| n-Nonyl β-D-glucopyranoside | NBS-231191 | 1g、5g、10g、25g、Bulk | 69984-73-2 |
| n-Decyl β-D-glucopyranoside (DG) > 99% highly purified | NBS-231192 | 1g、5g、10g、25g、Bulk | 58846-77-8 |
| n-Undecyl β-D-glucopyranoside (UDG) | NBS-231193 | 1g、5g、10g、25g、Bulk | 70005-86-6 |
| n-Dodecyl β-D-glucopyranoside | NBS-231194 | 1g、5g、10g、25g、Bulk | 59122-55-3 |
| 4-trans-(4-trans-Propylcyclohexyl)-cyclohexyl α-maltoside | NBS-231195 | 1g、5g、10g、25g、Bulk | N/A |
| n-Dodecyl α-maltoside | NBS-231196 | 1g、5g、10g、25g、Bulk | 116183-64-3 |
| n-Hexyl β-maltoside | NBS-231197 | 1g、5g、10g、25g、Bulk | 870287-95-9 |
| n-Heptyl β-maltoside | NBS-231198 | 1g、5g、10g、25g、Bulk | N/A |
| n-Octyl β-maltoside | NBS-231199 | 1g、5g、10g、25g、Bulk | 82494-08-4 |
| n-Nonyl β-maltoside | NBS-231200 | 1g、5g、10g、25g、Bulk | 106402-05-5 |
| n-Nonyl β-maltoside | NBS-231201 | 1g、5g、10g、25g、Bulk | 106402-05-5 |
| n-Decyl β-maltoside | NBS-231202 | 1g、5g、10g、25g、Bulk | 82494-09-5 |
| n-Decyl β-maltoside | NBS-231203 | 1g、5g、10g、25g、Bulk | 82494-09-5 |
| n-Undecyl β-maltoside | NBS-231204 | 1g、5g、10g、25g、Bulk | 253678-67-0 |
| n-Undecyl β-maltoside | NBS-231205 | 1g、5g、10g、25g、Bulk | 253678-67-0 |
| n-Dodecyl β-maltoside | NBS-231206 | 1g、5g、10g、25g、Bulk | 69227-93-6 |
| n-Tridecyl β-maltoside | NBS-231207 | 1g、5g、10g、25g、Bulk | 93911-12-7 |
| n-Tridecyl β-maltoside | NBS-231208 | 1g、5g、10g、25g、Bulk | 93911-12-7 |
| n-Tetradecyl β-maltoside | NBS-231209 | 1g、5g、10g、25g、Bulk | 18449-82-6 |
| n-Pentadecyl β-maltoside | NBS-231210 | 1g、5g、10g、25g、Bulk | N/A |
| n-Hexadecyl β-maltoside | NBS-231211 | 1g、5g、10g、25g、Bulk | 98064-96-1 |
| n-Dodecyl β-maltoside | NBS-231212 | 1g、5g、10g、25g、Bulk | 69227-93-6 |
| Isopropyl 1-thio-β-D-galactopyranoside | NBS-231213 | 1g、5g、10g、25g、Bulk | 367-93-1 |
| n-Heptyl 1-thio-β-D-glucopyranoside | NBS-231214 | 1g、5g、10g、25g、Bulk | 85618-20-8 |
| n-Octyl 1-thio-β-D-glucopyranoside | NBS-231215 | 1g、5g、10g、25g、Bulk | 85618-21-9 |
| n-Nonyl 1-thio-β-D-glucopyranoside | NBS-231216 | 1g、5g、10g、25g、Bulk | 98854-15-0 |
| n-Decyl 1-thio-β-D-glucopyranoside | NBS-231217 | 1g、5g、10g、25g、Bulk | 98854-16-1 |
| n-Dodecyl 1-thio-β-maltoside | NBS-231218 | 1g、5g、10g、25g、Bulk | 148565-58-6 |
| n-Heptyl 1-thio-β-D-glucopyranoside | NBS-231219 | 1g、5g、10g、25g、Bulk | 85618-20-8 |
| n-Octyl 1-thio-β-D-glucopyranoside | NBS-231220 | 1g、5g、10g、25g、Bulk | 85618-21-9 |
| MEGA-8 | NBS-231221 | 1g、5g、10g、25g、Bulk | 85316-98-9 |
| MEGA-9 | NBS-231222 | 1g、5g、10g、25g、Bulk | 85261-19-4 |
| MEGA-10 | NBS-231223 | 1g、5g、10g、25g、Bulk | 85261-19-4 |
| 1-O-(n-Octyl)-tetraethyleneglycol | NBS-231224 | 1g、5g、10g、25g、Bulk | 19327-39-0 |
| 1-O-(n-Decyl)-hexaethyleneglycol (C10E6) | NBS-231225 | 1g、5g、10g、25g、Bulk | 5168-89-8 |
| 1-O-(n-Decyl)-nonaethyleneglycol | NBS-231226 | 1g、5g、10g、25g、Bulk | 26183-52-81 |
| 1-O-(n-Dodecyl)-tetraethyleneglycol | NBS-231227 | 1g、5g、10g、25g、Bulk | 5274-68-0 |
| 1-O-(n-Dodecyl)-octaethyleneglycol | NBS-231228 | 1g、5g、10g、25g、Bulk | 3055-98-9 |
| 1-O-(n-Dodecyl)-nonaethyleneglycol | NBS-231229 | 1g、5g、10g、25g、Bulk | 3055-99-0 |
| 1-O-(n-Dodecyl)-decaethyleneglycol | NBS-231230 | 1g、5g、10g、25g、Bulk | 6540-99-4 |
| 1-O-(n-Tridecyl)-octaethyleneglycol | NBS-231231 | 1g、5g、10g、25g、Bulk | 9043-30-5 |
| N,N-Dimethyl-n-dodecylamine-N-oxide | NBS-231232 | 1g、5g、10g、25g、Bulk | 1643-20-5 |
| Sucrose monolaurate | NBS-231233 | 1g、5g、10g、25g、Bulk | 25339-99-5 |
| Monoolein | NBS-231234 | 1g、5g、10g、25g、Bulk | 111-03-5 |
| 3-[(3-Cholamidopropyl)-dimethylammonio]-1-propane sulfonate | NBS-231235 | 1g、5g、10g、25g、Bulk | 75621-03-3 |
| CHAPSO | NBS-231236 | 1g、5g、10g、25g、Bulk | 82473-24-3 |
| n-Nonylphosphocholine | NBS-231237 | 1g、5g、10g、25g、Bulk | 253678-64-7 |
| n-Decylphosphocholine | NBS-231238 | 1g、5g、10g、25g、Bulk | 70504-28-8 |
| n-Undecylphosphocholine | NBS-231239 | 1g、5g、10g、25g、Bulk | 253678-65-8 |
| n-Dodecylphosphocholine | NBS-231240 | 1g、5g、10g、25g、Bulk | 29557-51-5 |
| n-Tridecylphosphocholine | NBS-231241 | 1g、5g、10g、25g、Bulk | 85775-42-4 |
| n-Tetradecylphosphocholine | NBS-231242 | 1g、5g、10g、25g、Bulk | 77733-28-9 |
| n-Pentadecylphosphocholine | NBS-231243 | 1g、5g、10g、25g、Bulk | 146801-07-2 |
| n-Hexadecylphosphocholine | NBS-231244 | 1g、5g、10g、25g、Bulk | 58066-85-6 |
| α-D-Galactopyranose-phosphate di-potassium salt dihydrate | NBS-231245 | 1g、5g、10g、25g、Bulk | 19046-60-7 |
| α-D-Glucopyranose-phosphate di-potassium salt dihydrate | NBS-231246 | 1g、5g、10g、25g、Bulk | 5996-14-5 |
| α-D-Mannopyranose-phosphate di-potassium salt dihydrate | NBS-231247 | 1g、5g、10g、25g、Bulk | 71888-67-0 |
| N-Acetyl-D-galactosamine | NBS-231248 | 1g、5g、10g、25g、Bulk | 1811-31-0 |
| N-Acetyl-D-glucosamine | NBS-231249 | 1g、5g、10g、25g、Bulk | 7512-17-6 |
| 2-Acetamido-2-deoxy-β-D-glucopyranosylamin | NBS-231250 | 1g、5g、10g、25g、Bulk | 18615-50-4 |
| 2-Acetamido-2-deoxy-D-mannose monohydrate | NBS-231251 | 1g、5g、10g、25g、Bulk | 7772-94-3 |
| 1,3,4,6-tetra-O-acetyl-β-D-GlcNAc | NBS-231252 | 1g、5g、10g、25g、Bulk | 7772-79-4 |
| 3,4,6-tri-O-acetyl-β-D-GlcNAc azide | NBS-231253 | 1g、5g、10g、25g、Bulk | 6205-69-2 |
| 3,4,6-tri-O-acetyl-α-D-GlcNAc chlorid | NBS-231254 | 1g、5g、10g、25g、Bulk | 3068-34-6 |
| 1,3,4,6-tetra-O-acetyl-α-D-glucosamine x HCl | NBS-231255 | 1g、5g、10g、25g、Bulk | N/A |
| Allyl 2-acetamido-2-deoxy-α-D-glucopyranoside | NBS-231256 | 1g、5g、10g、25g、Bulk | 54400-75-8 |
| Allyl 2-acetamido-2-deoxy-β-D-glucopyranoside | NBS-231257 | 1g、5g、10g、25g、Bulk | 54400-77-0 |
| Allyl α-D-galactopyranoside | NBS-231258 | 1g、5g、10g、25g、Bulk | 48149-72-0 |
| Allyl α-D-glucopyranoside | NBS-231259 | 1g、5g、10g、25g、Bulk | 7464-56-4 |
| Allyl β-D-glucopyranoside | NBS-231260 | 1g、5g、10g、25g、Bulk | 34384-797 |
| Allyl α-D-mannopyranoside | NBS-231261 | 1g、5g、10g、25g、Bulk | 41308-76-3 |
| Allyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside | NBS-231262 | 1g、5g、10g、25g、Bulk | N/A |
| 1-Amino-1-deoxy-β-D-galactose | NBS-231263 | 1g、5g、10g、25g、Bulk | 50444-86-5 |
| 1,6-Anhydro-β-D-galactopyranose | NBS-231264 | 1g、5g、10g、25g、Bulk | 644-76-8 |
| 1,6:3,4-Dianhydro-2-O-tosyl--D-galactopyranose | NBS-231265 | 1g、5g、10g、25g、Bulk | 6167-32-4 |
| D-Arabinose | NBS-231266 | 1g、5g、10g、25g、Bulk | 28697-53-2 |
| Arbutin | NBS-231267 | 1g、5g、10g、25g、Bulk | 497-76-7 |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-galactopyranose | NBS-231268 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α,β-D-galacto-pyranose | NBS-231269 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose | NBS-231270 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,2‘,3,3‘,4‘,6,6‘-hepta-O-acetyl-α,β-lactose | NBS-231271 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-mannopyranose | NBS-231272 | 1g、5g、10g、25g、Bulk | N/A |
| Benzyl 4,6-O-benzylidene-α-D-GlcNAc | NBS-231273 | 1g、5g、10g、25g、Bulk | 13343-63-0 |
| Benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside | NBS-231274 | 1g、5g、10g、25g、Bulk | 13343-62-9 |
| Benzyl α-D-mannopyranoside | NBS-231275 | 1g、5g、10g、25g、Bulk | 155548-45-5 |
| Cellobiose | NBS-231276 | 1g、5g、10g、25g、Bulk | 528-50-7 |
| 6-Deoxy-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose | NBS-231277 | 1g、5g、10g、25g、Bulk | 4026-27-1 |
| 3,4-Di-O-acetyl-L-rhamnal | NBS-231278 | 1g、5g、10g、25g、Bulk | 34819-86-8 |
| 1,4:3,6-Dianhydro-D-mannitol | NBS-231279 | 1g、5g、10g、25g、Bulk | 641-74-7 |
| 1,2,3,4-Di-O-isopropylidene-α-D-galactopyranose | NBS-231280 | 1g、5g、10g、25g、Bulk | 4064-06-6 |
| 1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose | NBS-231281 | 1g、5g、10g、25g、Bulk | 582-52-5 |
| 1,2:5,6-Di-O-isopropylidene-D-mannitol | NBS-231282 | 1g、5g、10g、25g、Bulk | 1707-77-3 |
| 2,3:5,6-Di-O-isopropylidene-α-D-mannofuranose | NBS-231283 | 1g、5g、10g、25g、Bulk | 14131-84-1 |
| 1,2:3,5-Di-O-isopropylidene-α-D-xylofuranose | NBS-231284 | 1g、5g、10g、25g、Bulk | 20881-04-3 |
| D-Fucose | NBS-231285 | 1g、5g、10g、25g、Bulk | 3615-37-0 |
| L-Fucose | NBS-231286 | 1g、5g、10g、25g、Bulk | 2438-80-4 |
| D-Galactosamine x HCl | NBS-231287 | 1g、5g、10g、25g、Bulk | 1172-03-8 |
| D-Glucosamine x HCl | NBS-231288 | 1g、5g、10g、25g、Bulk | 66-84-2 |
| L-Glucose | NBS-231289 | 1g、5g、10g、25g、Bulk | 921-60-8 |
| 2,3,3’,4,6,6’-Hexa-O-acetyl-lactal | NBS-231290 | 1g、5g、10g、25g、Bulk | N/A |
| 1,2-O-Isopropylidene-α-D-glucofuranose | NBS-231291 | 1g、5g、10g、25g、Bulk | 18549-40-1 |
| Isopropyl-β-D-thiogalactoside | NBS-231292 | 1g、5g、10g、25g、Bulk | 367-93-1 |
| Isopropyl-β-D-thiogalactoside | NBS-231293 | 1g、5g、10g、25g、Bulk | 367-93-1 |
| 3,4-O-Isopropylidene-D-mannitol | NBS-231294 | 1g、5g、10g、25g、Bulk | 369-84-4 |
| 1,2-O-Isopropylidene-α-D-xylofuranose | NBS-231295 | 1g、5g、10g、25g、Bulk | 20031-21-4 |
| D-Lyxose | NBS-231296 | 1g、5g、10g、25g、Bulk | 1114-34-7 |
| L-Lyxose | NBS-231297 | 1g、5g、10g、25g、Bulk | 1949-78-6 |
| Maltose monohydrate | NBS-231298 | 1g、5g、10g、25g、Bulk | 6363-53-7 |
| β-Maltose octaacetate | NBS-231299 | 1g、5g、10g、25g、Bulk | 22352-19-8 |
| D-Mannose | NBS-231300 | 1g、5g、10g、25g、Bulk | 3458-28-4 |
| L-Mannose | NBS-231301 | 1g、5g、10g、25g、Bulk | 10030-80-5 |
| Methyl 4,6-O-benzylidene-β-D-galactopyranoside | NBS-231302 | 1g、5g、10g、25g、Bulk | 6988-39-2 |
| Methyl 4,6-O-benzylidene-α-D-glucopyranoside | NBS-231303 | 1g、5g、10g、25g、Bulk | 3162-96-7 |
| Methyl 4,6-O-benzylidene-β-D-glucopyranoside | NBS-231304 | 1g、5g、10g、25g、Bulk | 6988-39-2 |
| Methyl 6-deoxy-α-L-mannopyranoside | NBS-231305 | 1g、5g、10g、25g、Bulk | 15814-59-2 |
| Methyl α-D-fucopyranoside | NBS-231306 | 1g、5g、10g、25g、Bulk | 1128-40-1 |
| Methyl α-L-fucopyranoside | NBS-231307 | 1g、5g、10g、25g、Bulk | 14687-15-1 |
| Methyl β-D-galactopyranoside | NBS-231308 | 1g、5g、10g、25g、Bulk | 1824-94-8 |
| Methyl β-D-glucopyranoside hemihydrate | NBS-231309 | 1g、5g、10g、25g、Bulk | 7000-27-3 |
| Methyl β-D-ribopyranoside | NBS-231310 | 1g、5g、10g、25g、Bulk | 17289-61-1 |
| Methyl 2,3,5-tri-O-benzoyl-α-D-arabinofuranoside | NBS-231311 | 1g、5g、10g、25g、Bulk | N/A |
| 1,2,3,4,6-Penta-O-acetyl-β-D-galactopyranose | NBS-231312 | 1g、5g、10g、25g、Bulk | 4163-60-4 |
| 1,2,3,4,6-Penta-O-acetyl-α-D-mannopyranose | NBS-231313 | 1g、5g、10g、25g、Bulk | 4163-65-9 |
| D-Raffinose pentahydrate | NBS-231314 | 1g、5g、10g、25g、Bulk | 17629-30-0 |
| L-Rhamnose monohydrate | NBS-231315 | 1g、5g、10g、25g、Bulk | 10030-85-0 |
| D-Ribose | NBS-231316 | 1g、5g、10g、25g、Bulk | 50-69-1 |
| L-Ribose | NBS-231317 | 1g、5g、10g、25g、Bulk | 24259-59-4 |
| D-Tagatose | NBS-231318 | 1g、5g、10g、25g、Bulk | 87-81-0 |
| α-D-Talose | NBS-231319 | 1g、5g、10g、25g、Bulk | 2595-98-4 |
| 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl azide | NBS-231320 | 1g、5g、10g、25g、Bulk | 13992-26-2 |
| 2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl bromide | NBS-231321 | 1g、5g、10g、25g、Bulk | 3068-32-4 |
| 2,3,4,6-Tetra-O-acetyl--D-glucopyranosyl azide | NBS-231322 | 1g、5g、10g、25g、Bulk | 13992-25-1 |
| 2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl bromide | NBS-231323 | 1g、5g、10g、25g、Bulk | 572-09-8 |
| 1,3,4,6-Tetra-O-acetyl-β-D-mannopyranose | NBS-231324 | 1g、5g、10g、25g、Bulk | 18968-05-3 |
| 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranose | NBS-231325 | 1g、5g、10g、25g、Bulk | N/A |
| 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose | NBS-231326 | 1g、5g、10g、25g、Bulk | 13035-61-5 |
| 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-galactopyranose | NBS-231327 | 1g、5g、10g、25g、Bulk | N/A |
| 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-glucopyranose | NBS-231328 | 1g、5g、10g、25g、Bulk | 19879-84-6 |
| 2,3,4,6-Tetra-O-benzyl-α-D-galactopyranose | NBS-231329 | 1g、5g、10g、25g、Bulk | 5308-25-7 |
| 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranose | NBS-231330 | 1g、5g、10g、25g、Bulk | 4132-28-9 |
| 2,3,4,6-Tetra-O-benzyl-α-D-mannopyranose | NBS-231331 | 1g、5g、10g、25g、Bulk | 61330-61-8 |
| 1-Thio-β-D-galactose sodium salt | NBS-231332 | 1g、5g、10g、25g、Bulk | 42891-22-5 |
| 1-Thio-β-D-glucose sodium salt dihydrate | NBS-231333 | 1g、5g、10g、25g、Bulk | 10593-29-0 |
| 3,4,6-Tri-O-acetyl-D-galactal | NBS-231334 | 1g、5g、10g、25g、Bulk | 4098-06-0 |
| D-Turanose | NBS-231335 | 1g、5g、10g、25g、Bulk | 547-25-1 |
| D-Xylose | NBS-231336 | 1g、5g、10g、25g、Bulk | 58-86-6 |
| 1,6-Anhydro-β-D-glucopyranose | NBS-231337 | 1g、5g、10g、25g、Bulk | 498-07-7 |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-glucopyranose | NBS-231338 | 1g、5g、10g、25g、Bulk | N/A |
艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.
Berry & Associates的主要产品包括：
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸
艾美捷科技特约代理CUSABIO公司产品。Cusabio专注于研发生产基因、蛋白、抗体、ELISA试剂盒、体外诊断原料、小分子等产品，还涉及食品安全和药物残留领域。
CUSABIO is a National High-Tech Enterprise with research, production and sales in one. After 11 years of effort, CUSABIO has become a good partner to researchers through worldwide. We are dedicated to providing 60,000+ validated antibodies, 6000+ recombinant proteins, 580+ cytokines and thousands of ELISA kits to global customers in the research fields of cancer, cell biology, immunology, neuroscience, epigenetics, etc. All kinds of our products can meet customers' different demands in various scientific research fields.
Cusabio的主要产品包括：
（1）Kit
ELISA Kit
Elisa Kit For Food Safety & Drug Residues
Hot Product
Food Safety Small Molecule Antigen
（2）Protein
Native Protein
Recombinant Protein
Active Protein
Transmembrane Protein
（3）Antibody
Polyclonal Antibodies
Secondary Antibodies
Monoclonal Antibodies
Tag/Control Antibodies
Small Molecules Antibodies
ChIP Antibodies
Antibody Pairs
Recombinant Antibodies
Custom Antibodies
（4）Molecular Biology Product
RT-PCR Primers
Clone
Tools Enzyme
Other Small Molecule Antigen
Peptide
（5）Wisherkon Food Safety Test Kits
ELISA Test Kits
Rapid Test Card/Strip
Chemical Reagents
（6）Raw Material For IVD Kit
CUSAg
" data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Cusabio"> Cusabio
Rocky Mountain Diagnostics公司成立于2001年，主要产品涉及生物胺类、内分泌学、食品安全、研究分析/研究高敏感度、唾液试验、酶联免疫试剂盒等。
RMD was established in 2001 with a vision of marketing high quality in vitro diagnostics in the US. This vision, combined with the more than 40 years of experience of our partner organizations and exclusive dedication to immunodiagnostics, has made RMD together with its parent company the worldwide leaders in biogenic amine assays.
Rocky Mountain Diagnostics公司主要产品：
Biogenic Amines
Endocrinology
Food Safety - Featuring Histasure
Research Assays / Research High-Sensitive
Salivary Assays
Elisa Kit
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Rocky Mountain Diagnostics"> Rocky Mountain Diagnostics地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：17754422825
传真：15172431432
邮箱：sales@amyjet.com
0.409
